AGCO CORP /DE 0000880266--12-31 2023 Q1 false 33.33 33.33 33.33 1.5 P4Y P1Y http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member 9 1 1 1 0000880266 2023-01-01 2023-03-31 0000880266 2023-05-05 xbrli:shares 0000880266 2023-03-31 iso4217:USD 0000880266 2022-12-31 iso4217:USD xbrli:shares 0000880266 2022-01-01 2022-03-31 0000880266 2021-12-31 0000880266 2022-03-31 0000880266 srt:SubsidiariesMember country:TR 2023-01-01 2023-03-31 0000880266 srt:SubsidiariesMember country:TR 2023-03-31 0000880266 currency:TRY srt:SubsidiariesMember country:TR 2023-03-31 iso4217:TRY 0000880266 country:AR 2023-03-31 iso4217:ARS 0000880266 agco:AGCOCapitalArgentinaSAMember 2023-03-31 0000880266 country:AR agco:FinanceJointVenturesMember 2023-03-31 0000880266 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2022-12-31 0000880266 agco:JCAMember 2022-05-02 2022-05-02 iso4217:CAD 0000880266 agco:JCAMember 2022-05-02 0000880266 agco:AppareoMember 2022-01-01 2022-01-01 0000880266 agco:AppareoMember 2022-01-01 xbrli:pure 0000880266 agco:AppareoMember 2022-01-01 0000880266 agco:JCAAndAppareoMember us-gaap:CustomerRelationshipsMember 2022-12-31 0000880266 agco:JCAAndAppareoMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0000880266 agco:JCAAndAppareoMember us-gaap:TrademarksMember 2022-12-31 0000880266 us-gaap:NoncompeteAgreementsMember agco:JCAAndAppareoMember 2022-12-31 0000880266 agco:JCAAndAppareoMember 2022-12-31 0000880266 agco:EntityUnderTimeLimitedGeneralLicenseMember agco:RussianFinanceJointVentureMember 2022-01-01 2022-03-31 0000880266 agco:RussianFinanceJointVentureMember 2022-01-01 2022-03-31 0000880266 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0000880266 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0000880266 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0000880266 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0000880266 agco:TwoThousandSixPlanMember 2023-03-31 0000880266 us-gaap:PerformanceSharesMember 2023-01-01 2023-03-31 0000880266 us-gaap:PerformanceSharesMember 2022-01-01 2022-03-31 0000880266 us-gaap:PerformanceSharesMember 2022-12-31 0000880266 us-gaap:PerformanceSharesMember 2023-03-31 0000880266 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0000880266 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0000880266 agco:A2020GrantsMember us-gaap:RestrictedStockUnitsRSUMember agco:CertainExecutivesMember 2023-01-01 2023-03-31 0000880266 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000880266 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0000880266 us-gaap:StockAppreciationRightsSARSMember 2023-03-31 0000880266 us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-03-31 0000880266 us-gaap:SubsequentEventMember us-gaap:RestrictedStockMember 2023-04-27 2023-04-27 0000880266 us-gaap:SubsequentEventMember us-gaap:RestrictedStockMember 2023-04-27 2023-04-30 0000880266 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-03-31 0000880266 us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0000880266 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-03-31 0000880266 srt:NorthAmericaMember 2022-12-31 0000880266 srt:SouthAmericaMember 2022-12-31 0000880266 agco:EMEMember 2022-12-31 0000880266 agco:APAMember 2022-12-31 0000880266 srt:NorthAmericaMember 2023-01-01 2023-03-31 0000880266 srt:SouthAmericaMember 2023-01-01 2023-03-31 0000880266 agco:EMEMember 2023-01-01 2023-03-31 0000880266 agco:APAMember 2023-01-01 2023-03-31 0000880266 srt:NorthAmericaMember 2023-03-31 0000880266 srt:SouthAmericaMember 2023-03-31 0000880266 agco:EMEMember 2023-03-31 0000880266 agco:APAMember 2023-03-31 0000880266 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0000880266 us-gaap:CustomerRelationshipsMember 2022-12-31 0000880266 agco:TechnologyAndPatentsMember 2022-12-31 0000880266 us-gaap:UseRightsMember 2022-12-31 0000880266 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-03-31 0000880266 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-03-31 0000880266 agco:TechnologyAndPatentsMember 2023-01-01 2023-03-31 0000880266 us-gaap:UseRightsMember 2023-01-01 2023-03-31 0000880266 us-gaap:TrademarksAndTradeNamesMember 2023-03-31 0000880266 us-gaap:CustomerRelationshipsMember 2023-03-31 0000880266 agco:TechnologyAndPatentsMember 2023-03-31 0000880266 us-gaap:UseRightsMember 2023-03-31 0000880266 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0000880266 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-03-31 0000880266 us-gaap:TrademarksAndTradeNamesMember 2023-03-31 0000880266 srt:MinimumMember 2023-03-31 0000880266 srt:MaximumMember 2023-03-31 0000880266 agco:RevolvingCreditFacilityAndTermLoanExpires2027Member 2023-03-31 0000880266 agco:RevolvingCreditFacilityAndTermLoanExpires2027Member 2022-12-31 0000880266 agco:SeniorNotesDue20251.002Member 2019-01-25 0000880266 agco:SeniorNotesDue20251.002MemberMember 2023-03-31 0000880266 agco:SeniorNotesDue20251.002MemberMember 2022-12-31 0000880266 agco:SeniorTermLoansDueBetween2023And2028Member 2023-03-31 0000880266 agco:SeniorTermLoansDueBetween2023And2028Member 2022-12-31 0000880266 agco:A0800SeniorNotesDue2028Member 2021-10-06 0000880266 agco:A0800SeniorNotesDue2028Member 2023-03-31 0000880266 agco:A0800SeniorNotesDue2028Member 2022-12-31 0000880266 agco:SeniorTermLoansDue2023Member 2023-03-31 0000880266 agco:SeniorTermLoansDue2023Member 2022-12-31 0000880266 agco:OtherLongTermDebtMember 2023-03-31 0000880266 agco:OtherLongTermDebtMember 2022-12-31 0000880266 us-gaap:LineOfCreditMember agco:A125BillionMultiCurrencyUnsecuredCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2022-12-31 0000880266 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2018-10-31 0000880266 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-12-01 2022-12-31 0000880266 agco:BilateralRevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-12-01 2022-12-31 0000880266 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember agco:A125BillionMultiCurrencyUnsecuredCreditFacilityUSDollarTrancheMember 2022-12-31 0000880266 agco:A125BillionMultiCurrencyUnsecuredCreditFacilityMultiCurrencyTrancheMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-12-31 0000880266 agco:InterestAccrualOptionOneMember agco:MultiCurrencyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:InterestAccrualOptionOneMember agco:MultiCurrencyRevolvingCreditFacilityMember srt:MinimumMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:InterestAccrualOptionOneMember agco:MultiCurrencyRevolvingCreditFacilityMember srt:MaximumMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:MultiCurrencyRevolvingCreditFacilityMember agco:InterestAccrualOptionTwoMember us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:MultiCurrencyRevolvingCreditFacilityMember agco:InterestAccrualOptionTwoMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:MultiCurrencyRevolvingCreditFacilityMember srt:MinimumMember agco:InterestAccrualOptionTwoMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:MultiCurrencyRevolvingCreditFacilityMember agco:InterestAccrualOptionTwoMember srt:MaximumMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-31 0000880266 agco:MultiCurrencyRevolvingCreditFacilityMember srt:MinimumMember us-gaap:LineOfCreditMember agco:EuroInterbankOfferedRateEURIBORMember 2022-12-01 2022-12-31 0000880266 agco:MultiCurrencyRevolvingCreditFacilityMember srt:MaximumMember us-gaap:LineOfCreditMember agco:EuroInterbankOfferedRateEURIBORMember 2022-12-01 2022-12-31 0000880266 agco:TermLoanFacilityMember 2023-03-31 0000880266 us-gaap:LineOfCreditMember agco:A125BillionMultiCurrencyUnsecuredCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2023-03-31 0000880266 us-gaap:RevolvingCreditFacilityMember agco:UncommittedRevolvingCreditFacilityMember 2022-06-30 iso4217:EUR 0000880266 us-gaap:RevolvingCreditFacilityMember agco:UncommittedRevolvingCreditFacilityMember 2023-03-31 0000880266 2021-10-06 2021-10-06 0000880266 agco:SeniorNotesDue20251.002MemberMember 2019-01-25 0000880266 agco:SeniorTermLoansDueBetween2023And2028Member 2016-10-31 0000880266 2016-10-31 agco:loan_agreement 0000880266 agco:SeniorTermLoansDueBetween2023And2028Member 2018-08-31 0000880266 2018-08-31 0000880266 agco:SeniorTermLoansDueBetween2023And2028Member 2019-10-01 2022-04-30 0000880266 agco:SeniorTermLoansDueBetween2023And2028Member 2021-08-01 2022-02-28 0000880266 agco:TermLoanFacilityMember agco:SeniorTermLoansDueBetween2023And2028Member 2023-03-31 0000880266 srt:MinimumMember us-gaap:LineOfCreditMember 2023-01-01 2023-03-31 0000880266 srt:MaximumMember us-gaap:LineOfCreditMember 2023-01-01 2023-03-31 0000880266 srt:MinimumMember us-gaap:LineOfCreditMember agco:EuroInterbankOfferedRateEURIBORMember 2023-01-01 2023-03-31 0000880266 us-gaap:StockAppreciationRightsSARSMember 2022-01-01 2022-03-31 0000880266 us-gaap:ForeignCountryMember 2023-03-31 0000880266 us-gaap:ForeignCountryMember 2022-12-31 iso4217:BRL 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-12-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2022-12-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000880266 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ForeignExchangeContractMember 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:CommodityContractMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember agco:CrossCurrencyInterestRateContractPaymentMember us-gaap:NetInvestmentHedgingMember srt:ScenarioForecastMember 2028-01-29 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember agco:CrossCurrencyInterestRateContractPaymentMember us-gaap:NetInvestmentHedgingMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember srt:ScenarioForecastMember agco:CrossCurrencyInterestRateContractReceiptMember 2028-01-29 0000880266 agco:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember us-gaap:CrossCurrencyInterestRateContractMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember us-gaap:CrossCurrencyInterestRateContractMember 2022-12-31 0000880266 agco:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2022-12-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CrossCurrencyInterestRateContractMember 2023-01-01 2023-03-31 0000880266 agco:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CrossCurrencyInterestRateContractMember 2022-01-01 2022-03-31 0000880266 agco:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000880266 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2023-03-31 0000880266 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2022-12-31 0000880266 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember 2023-03-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-12-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CommodityContractMember 2022-12-31 0000880266 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember 2022-12-31 0000880266 us-gaap:CommonStockMember 2022-12-31 0000880266 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000880266 us-gaap:RetainedEarningsMember 2022-12-31 0000880266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000880266 us-gaap:NoncontrollingInterestMember 2022-12-31 0000880266 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000880266 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000880266 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000880266 2022-01-01 2022-12-31 0000880266 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2022-12-31 0000880266 us-gaap:CommonStockMember 2023-03-31 0000880266 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000880266 us-gaap:RetainedEarningsMember 2023-03-31 0000880266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000880266 us-gaap:NoncontrollingInterestMember 2023-03-31 0000880266 us-gaap:CommonStockMember 2021-12-31 0000880266 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000880266 us-gaap:RetainedEarningsMember 2021-12-31 0000880266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000880266 us-gaap:NoncontrollingInterestMember 2021-12-31 0000880266 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000880266 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000880266 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000880266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000880266 us-gaap:CommonStockMember 2022-03-31 0000880266 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000880266 us-gaap:RetainedEarningsMember 2022-03-31 0000880266 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000880266 us-gaap:NoncontrollingInterestMember 2022-03-31 0000880266 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0000880266 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000880266 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0000880266 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CommodityContractMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CommodityContractMember 2022-01-01 2022-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2023-01-01 2023-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2022-01-01 2022-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2023-01-01 2023-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2022-01-01 2022-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000880266 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000880266 2021-11-01 2021-11-30 0000880266 2021-11-01 2021-12-31 0000880266 agco:AcceleratedShareRepurchaseMember 2022-01-19 2022-01-19 0000880266 us-gaap:SubsequentEventMember 2023-04-27 2023-04-27 0000880266 agco:UnitedStatesCanadaEuropeandBrazilMember 2023-03-31 0000880266 agco:UnitedStatesCanadaEuropeandBrazilMember 2022-12-31 0000880266 us-gaap:TradeAccountsReceivableMember 2023-03-31 0000880266 us-gaap:TradeAccountsReceivableMember 2022-12-31 0000880266 us-gaap:OtherExpenseMember 2023-01-01 2023-03-31 0000880266 us-gaap:OtherExpenseMember 2022-01-01 2022-03-31 0000880266 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-03-31 0000880266 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000880266 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-03-31 0000880266 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000880266 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2023-01-01 2023-03-31 0000880266 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2023-01-01 2023-03-31 0000880266 us-gaap:PensionPlansDefinedBenefitMember 2023-03-31 0000880266 us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2023-01-01 2023-03-31 0000880266 us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2023-03-31 0000880266 us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880266 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880266 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000880266 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000880266 us-gaap:FairValueInputsLevel3Member 2022-12-31 agco:reportable_segment 0000880266 us-gaap:OperatingSegmentsMember agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:SouthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:SouthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:NorthAmericaSegmentMember 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:SouthAmericaSegmentMember 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:EMESegmentMember 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:APASegmentMember 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember 2023-03-31 0000880266 us-gaap:OperatingSegmentsMember agco:NorthAmericaSegmentMember 2022-12-31 0000880266 us-gaap:OperatingSegmentsMember agco:SouthAmericaSegmentMember 2022-12-31 0000880266 us-gaap:OperatingSegmentsMember agco:EMESegmentMember 2022-12-31 0000880266 us-gaap:OperatingSegmentsMember agco:APASegmentMember 2022-12-31 0000880266 us-gaap:OperatingSegmentsMember 2022-12-31 0000880266 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0000880266 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-03-31 0000880266 us-gaap:MaterialReconcilingItemsMember 2023-03-31 0000880266 us-gaap:MaterialReconcilingItemsMember 2022-12-31 0000880266 agco:RetailFinanceJointVentureMember 2023-01-01 2023-03-31 0000880266 agco:OtherJointVenturesMember 2023-03-31 0000880266 us-gaap:ForeignExchangeContractMember 2023-03-31 0000880266 agco:ExtendedWarrantContractsMaintenanceServicesTechnologyServicesMember 2023-01-01 2023-03-31 0000880266 agco:ExtendedWarrantContractsMaintenanceServicesTechnologyServicesMember 2022-01-01 2022-03-31 0000880266 agco:GrainStorageAndProteinProductionSystemsMember 2023-01-01 2023-03-31 0000880266 agco:GrainStorageAndProteinProductionSystemsMember 2022-01-01 2022-03-31 0000880266 2023-04-01 2023-03-31 0000880266 2024-01-01 2023-03-31 0000880266 2025-01-01 2023-03-31 0000880266 2026-01-01 2023-03-31 0000880266 2027-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember country:US 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember country:US 2023-01-01 2023-03-31 0000880266 country:US agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember country:US 2023-01-01 2023-03-31 0000880266 country:US 2023-01-01 2023-03-31 0000880266 country:CA agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember country:CA 2023-01-01 2023-03-31 0000880266 country:CA agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 country:CA agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 country:CA 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember country:BR 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember country:BR 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember country:BR 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember country:BR 2023-01-01 2023-03-31 0000880266 country:BR 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:OtherSouthAmericaMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:OtherSouthAmericaMember 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember agco:OtherSouthAmericaMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:OtherSouthAmericaMember 2023-01-01 2023-03-31 0000880266 agco:OtherSouthAmericaMember 2023-01-01 2023-03-31 0000880266 country:DE agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember country:DE 2023-01-01 2023-03-31 0000880266 country:DE agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 country:DE agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 country:DE 2023-01-01 2023-03-31 0000880266 country:FR agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember country:FR 2023-01-01 2023-03-31 0000880266 country:FR agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 country:FR agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 country:FR 2023-01-01 2023-03-31 0000880266 agco:UnitedKingdomAndIrelandMember agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:UnitedKingdomAndIrelandMember 2023-01-01 2023-03-31 0000880266 agco:UnitedKingdomAndIrelandMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:UnitedKingdomAndIrelandMember agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 agco:UnitedKingdomAndIrelandMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:FinlandAndScandinaviaMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:FinlandAndScandinaviaMember 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember agco:FinlandAndScandinaviaMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:FinlandAndScandinaviaMember 2023-01-01 2023-03-31 0000880266 agco:FinlandAndScandinaviaMember 2023-01-01 2023-03-31 0000880266 country:IT agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 country:IT agco:SouthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 country:IT agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 country:IT agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 country:IT 2023-01-01 2023-03-31 0000880266 agco:OtherEuropeMember agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:OtherEuropeMember 2023-01-01 2023-03-31 0000880266 agco:OtherEuropeMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:OtherEuropeMember agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 agco:OtherEuropeMember 2023-01-01 2023-03-31 0000880266 agco:MiddleEastandAlgeriaMember agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:MiddleEastandAlgeriaMember 2023-01-01 2023-03-31 0000880266 agco:MiddleEastandAlgeriaMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:MiddleEastandAlgeriaMember agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 agco:MiddleEastandAlgeriaMember 2023-01-01 2023-03-31 0000880266 srt:AfricaMember agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember srt:AfricaMember 2023-01-01 2023-03-31 0000880266 srt:AfricaMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 srt:AfricaMember agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 srt:AfricaMember 2023-01-01 2023-03-31 0000880266 srt:AsiaMember agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember srt:AsiaMember 2023-01-01 2023-03-31 0000880266 srt:AsiaMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 srt:AsiaMember agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 srt:AsiaMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:AustraliaAndNewZealandMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:AustraliaAndNewZealandMember 2023-01-01 2023-03-31 0000880266 agco:AustraliaAndNewZealandMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:AustraliaAndNewZealandMember 2023-01-01 2023-03-31 0000880266 agco:AustraliaAndNewZealandMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2023-01-01 2023-03-31 0000880266 agco:MexicoCentralAmericaAndCaribbeanMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:TractorsMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:TractorsMember 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember agco:TractorsMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:TractorsMember 2023-01-01 2023-03-31 0000880266 agco:TractorsMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:ReplacementPartSalesMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:ReplacementPartSalesMember 2023-01-01 2023-03-31 0000880266 agco:ReplacementPartSalesMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:ReplacementPartSalesMember 2023-01-01 2023-03-31 0000880266 agco:ReplacementPartSalesMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2023-01-01 2023-03-31 0000880266 agco:EMESegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember agco:ApplicationEquipmentProductLineMember 2023-01-01 2023-03-31 0000880266 agco:SouthAmericaSegmentMember agco:ApplicationEquipmentProductLineMember 2023-01-01 2023-03-31 0000880266 agco:ApplicationEquipmentProductLineMember agco:EMESegmentMember 2023-01-01 2023-03-31 0000880266 agco:APASegmentMember agco:ApplicationEquipmentProductLineMember 2023-01-01 2023-03-31 0000880266 agco:ApplicationEquipmentProductLineMember 2023-01-01 2023-03-31 0000880266 agco:NorthAmericaSegmentMember country:US 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember country:US 2022-01-01 2022-03-31 0000880266 country:US agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember country:US 2022-01-01 2022-03-31 0000880266 country:US 2022-01-01 2022-03-31 0000880266 country:CA agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember country:CA 2022-01-01 2022-03-31 0000880266 country:CA agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 country:CA agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 country:CA 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember country:BR 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember country:BR 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember country:BR 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember country:BR 2022-01-01 2022-03-31 0000880266 country:BR 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:OtherSouthAmericaMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:OtherSouthAmericaMember 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember agco:OtherSouthAmericaMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:OtherSouthAmericaMember 2022-01-01 2022-03-31 0000880266 agco:OtherSouthAmericaMember 2022-01-01 2022-03-31 0000880266 country:DE agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember country:DE 2022-01-01 2022-03-31 0000880266 country:DE agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 country:DE agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 country:DE 2022-01-01 2022-03-31 0000880266 country:FR agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember country:FR 2022-01-01 2022-03-31 0000880266 country:FR agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 country:FR agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 country:FR 2022-01-01 2022-03-31 0000880266 agco:UnitedKingdomAndIrelandMember agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:UnitedKingdomAndIrelandMember 2022-01-01 2022-03-31 0000880266 agco:UnitedKingdomAndIrelandMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:UnitedKingdomAndIrelandMember agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 agco:UnitedKingdomAndIrelandMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:FinlandAndScandinaviaMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:FinlandAndScandinaviaMember 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember agco:FinlandAndScandinaviaMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:FinlandAndScandinaviaMember 2022-01-01 2022-03-31 0000880266 agco:FinlandAndScandinaviaMember 2022-01-01 2022-03-31 0000880266 country:IT agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 country:IT agco:SouthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 country:IT agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 country:IT agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 country:IT 2022-01-01 2022-03-31 0000880266 agco:OtherEuropeMember agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:OtherEuropeMember 2022-01-01 2022-03-31 0000880266 agco:OtherEuropeMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:OtherEuropeMember agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 agco:OtherEuropeMember 2022-01-01 2022-03-31 0000880266 agco:MiddleEastandAlgeriaMember agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:MiddleEastandAlgeriaMember 2022-01-01 2022-03-31 0000880266 agco:MiddleEastandAlgeriaMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:MiddleEastandAlgeriaMember agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 agco:MiddleEastandAlgeriaMember 2022-01-01 2022-03-31 0000880266 srt:AfricaMember agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember srt:AfricaMember 2022-01-01 2022-03-31 0000880266 srt:AfricaMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 srt:AfricaMember agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 srt:AfricaMember 2022-01-01 2022-03-31 0000880266 srt:AsiaMember agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember srt:AsiaMember 2022-01-01 2022-03-31 0000880266 srt:AsiaMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 srt:AsiaMember agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 srt:AsiaMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:AustraliaAndNewZealandMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:AustraliaAndNewZealandMember 2022-01-01 2022-03-31 0000880266 agco:AustraliaAndNewZealandMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:AustraliaAndNewZealandMember 2022-01-01 2022-03-31 0000880266 agco:AustraliaAndNewZealandMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:MexicoCentralAmericaAndCaribbeanMember 2022-01-01 2022-03-31 0000880266 agco:MexicoCentralAmericaAndCaribbeanMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:TractorsMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:TractorsMember 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember agco:TractorsMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:TractorsMember 2022-01-01 2022-03-31 0000880266 agco:TractorsMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:ReplacementPartSalesMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:ReplacementPartSalesMember 2022-01-01 2022-03-31 0000880266 agco:ReplacementPartSalesMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:ReplacementPartSalesMember 2022-01-01 2022-03-31 0000880266 agco:ReplacementPartSalesMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2022-01-01 2022-03-31 0000880266 agco:EMESegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:GrainStorageAndProteinProductionSystemsMember 2022-01-01 2022-03-31 0000880266 agco:NorthAmericaSegmentMember agco:ApplicationEquipmentProductLineMember 2022-01-01 2022-03-31 0000880266 agco:SouthAmericaSegmentMember agco:ApplicationEquipmentProductLineMember 2022-01-01 2022-03-31 0000880266 agco:ApplicationEquipmentProductLineMember agco:EMESegmentMember 2022-01-01 2022-03-31 0000880266 agco:APASegmentMember agco:ApplicationEquipmentProductLineMember 2022-01-01 2022-03-31 0000880266 agco:ApplicationEquipmentProductLineMember 2022-01-01 2022-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| For the transition period from _________ to _________

Commission File Number: 001-12930
AGCO CORPORATION
(Exact name of Registrant as specified in its charter)

Delaware |  | 58-1960019
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
4205 River Green Parkway |  |
Duluth, | Georgia |  | 30096
(Address of principal executive offices) |  | (Zip Code)

(770) 813-9200
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act
Title of Class | Trading Symbol | Name of exchange on which registered
Common stock | AGCO | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
☒ Yes o No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
☒ Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☒ | Large accelerated filer | ☐ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ | Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
As of May 5, 2023, there were 74,864,170 shares of the registrant’s common stock, par value of $0.01 per share, outstanding.

AGCO CORPORATION AND SUBSIDIARIES
INDEX

|  |  | Page Numbers
PART I. FINANCIAL INFORMATION:
Item 1. | Financial Statements (unaudited) |
|  | Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 | 3
|  | Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022 | 4
|  | Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2023 and 2022 | 5
|  | Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022 | 6
| Notes to Condensed Consolidated Financial Statements | 7
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 31
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 40
Item 4. | Controls and Procedures | 40
PART II. OTHER INFORMATION: |
Item 1. | Legal Proceedings | 41
Item 1A. | Risk Factors | 41
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 41
Item 6. | Exhibits | 42
SIGNATURES | 43

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
AGCO CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited and in millions, except share amounts)

| March 31, 2023 |  | December 31, 2022
ASSETS
Current Assets: |  |  |
Cash, cash equivalents and restricted cash | $ | 558.7 |  |  | $ | 789.5 |
Accounts and notes receivable, net | 1,530.7 |  |  | 1,221.3 |
Inventories, net | 3,642.8 |  |  | 3,189.7 |
Other current assets | 596.6 |  |  | 538.8 |
Total current assets | 6,328.8 |  |  | 5,739.3 |
Property, plant and equipment, net | 1,668.7 |  |  | 1,591.2 |
Right-of-use lease assets | 160.8 |  |  | 163.9 |
Investments in affiliates | 456.5 |  |  | 436.9 |
Deferred tax assets | 232.9 |  |  | 228.5 |
Other assets | 287.4 |  |  | 268.7 |
Intangible assets, net | 354.0 |  |  | 364.4 |
Goodwill | 1,322.5 |  |  | 1,310.8 |
Total assets | $ | 10,811.6 |  |  | $ | 10,103.7 |
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities: |  |  |
Current portion of long-term debt | $ | 190.6 |  |  | $ | 187.1 |
Short-term borrowings | 4.9 |  |  | 8.9 |
Accounts payable | 1,426.6 |  |  | 1,385.3 |
Accrued expenses | 2,144.3 |  |  | 2,271.3 |
Other current liabilities | 217.9 |  |  | 235.4 |
Total current liabilities | 3,984.3 |  |  | 4,088.0 |
Long-term debt, less current portion and debt issuance costs | 1,791.1 |  |  | 1,264.8 |
Operating lease liabilities | 122.3 |  |  | 125.4 |
Pension and postretirement health care benefits | 160.1 |  |  | 158.0 |
Deferred tax liabilities | 115.3 |  |  | 112.0 |
Other noncurrent liabilities | 505.6 |  |  | 472.9 |
Total liabilities | 6,678.7 |  |  | 6,221.1 |
Commitments and contingencies (Note 19) |  |  |
Stockholders’ Equity: |  |  |
AGCO Corporation stockholders’ equity: |  |  |
Preferred stock; $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding in 2023 and 2022 | — |  |  | — |
Common stock; $0.01 par value, 150,000,000 shares authorized, 74,846,174 and 74,600,815 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 0.7 |  |  | 0.7 |
Additional paid-in capital | 24.7 |  |  | 30.2 |
Retained earnings | 5,863.7 |  |  | 5,654.6 |
Accumulated other comprehensive loss | (1,756.4) |  |  | (1,803.1) |
Total AGCO Corporation stockholders’ equity | 4,132.7 |  |  | 3,882.4 |
Noncontrolling interests | 0.2 |  |  | 0.2 |
Total stockholders’ equity | 4,132.9 |  |  | 3,882.6 |
Total liabilities and stockholders’ equity | $ | 10,811.6 |  |  | $ | 10,103.7 |

See accompanying notes to condensed consolidated financial statements.
3

Table of Contents
AGCO CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited and in millions, except per share data)

| Three Months Ended March 31,
| 2023 |  | 2022
Net sales | $ | 3,333.5 |  |  | $ | 2,685.7 |
Cost of goods sold | 2,478.6 |  |  | 2,054.4 |
Gross profit | 854.9 |  |  | 631.3 |
Operating expenses: |  |  |
Selling, general and administrative expenses | 330.3 |  |  | 271.1 |
Engineering expenses | 119.6 |  |  | 100.3 |
Amortization of intangibles | 14.8 |  |  | 15.3 |
Impairment charges | — |  |  | 36.0 |
Restructuring expenses | 1.4 |  |  | 3.0 |
Bad debt expense | 1.5 |  |  | 1.6 |
Income from operations | 387.3 |  |  | 204.0 |
Interest expense, net | 0.5 |  |  | 0.4 |
Other expense, net | 50.4 |  |  | 17.5 |
Income before income taxes and equity in net earnings of affiliates | 336.4 |  |  | 186.1 |
Income tax provision | 120.2 |  |  | 60.2 |
Income before equity in net earnings of affiliates | 216.2 |  |  | 125.9 |
Equity in net earnings of affiliates | 16.4 |  |  | 11.1 |
Net income | 232.6 |  |  | 137.0 |
Net income attributable to noncontrolling interests | — |  |  | 14.8 |
Net income attributable to AGCO Corporation and subsidiaries | $ | 232.6 |  |  | $ | 151.8 |
Net income per common share attributable to AGCO Corporation and subsidiaries: |  |  |
Basic | $ | 3.11 |  |  | $ | 2.03 |
Diluted | $ | 3.10 |  |  | $ | 2.03 |
Cash dividends declared and paid per common share | $ | 0.24 |  |  | $ | 0.20 |
Weighted average number of common and common equivalent shares outstanding: |  |  |
Basic | 74.9 |  |  | 74.6 |
Diluted | 75.0 |  |  | 74.9 |

See accompanying notes to condensed consolidated financial statements.
4

Table of Contents
AGCO CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(unaudited and in millions)

| Three Months Ended March 31,
| 2023 |  | 2022
Net income | $ | 232.6 |  |  | $ | 137.0 |
Other comprehensive income, net of reclassification adjustments: |  |  |
Foreign currency translation adjustments | 44.4 |  |  | 138.3 |
Defined benefit pension plans, net of tax | 1.8 |  |  | 1.7 |
Deferred gains and losses on derivatives, net of tax | 0.5 |  |  | (3.3) |
Other comprehensive income, net of reclassification adjustments | 46.7 |  |  | 136.7 |
Comprehensive income | 279.3 |  |  | 273.7 |
Comprehensive income attributable to noncontrolling interests | — |  |  | 14.0 |
Comprehensive income attributable to AGCO Corporation and subsidiaries | $ | 279.3 |  |  | $ | 287.7 |

See accompanying notes to condensed consolidated financial statements.
5

Table of Contents
AGCO CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited and in millions)

| Three Months Ended March 31,
| 2023 |  | 2022
Cash flows from operating activities: |  |  |
Net income | $ | 232.6 |  |  | $ | 137.0 |
Adjustments to reconcile net income to net cash used in operating activities: |  |  |
Depreciation | 53.6 |  |  | 54.7 |
Amortization of intangibles | 14.8 |  |  | 15.3 |
Stock compensation expense | 14.0 |  |  | 7.0 |
Impairment charges | — |  |  | 36.0 |
Equity in net earnings of affiliates, net of cash received | (16.4) |  |  | (11.1) |
Deferred income tax benefit | (3.9) |  |  | (5.0) |
Other | 2.4 |  |  | (8.8) |
Changes in operating assets and liabilities: |  |  |
Accounts and notes receivable, net | (298.1) |  |  | (113.3) |
Inventories, net | (402.6) |  |  | (595.2) |
Other current and noncurrent assets | (69.9) |  |  | (48.7) |
Accounts payable | 39.2 |  |  | 193.4 |
Accrued expenses | (155.9) |  |  | (219.5) |
Other current and noncurrent liabilities | 33.1 |  |  | (18.3) |
Total adjustments | (789.7) |  |  | (713.5) |
Net cash used in operating activities | (557.1) |  |  | (576.5) |
Cash flows from investing activities: |  |  |
Purchases of property, plant and equipment | (125.3) |  |  | (66.3) |
Proceeds from sale of property, plant and equipment | 0.1 |  |  | 0.3 |
Investments in unconsolidated affiliates | (0.1) |  |  | (0.1) |
Purchase businesses, net, and net of cash acquired | (0.9) |  |  | (61.9) |
Other | (2.6) |  |  | — |
Net cash used in investing activities | (128.8) |  |  | (128.0) |
Cash flows from financing activities: |  |  |
Proceeds from indebtedness | 501.7 |  |  | 980.7 |
Repayments of indebtedness | (4.4) |  |  | (459.1) |
Payment of dividends to stockholders | (18.0) |  |  | (14.9) |
Payment of minimum tax withholdings on stock compensation | (17.7) |  |  | (16.0) |
Distributions to noncontrolling interest | — |  |  | (11.6) |
Net cash provided by financing activities | 461.6 |  |  | 479.1 |
Effects of exchange rate changes on cash, cash equivalents and restricted cash | (6.5) |  |  | (8.0) |
Decrease in cash, cash equivalents and restricted cash | (230.8) |  |  | (233.4) |
Cash, cash equivalents and restricted cash, beginning of period | 789.5 |  |  | 889.1 |
Cash, cash equivalents and restricted cash, end of period | $ | 558.7 |  |  | $ | 655.7 |

See accompanying notes to condensed consolidated financial statements.
6

Table of Contents
AGCO CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. BASIS OF PRESENTATION
The condensed consolidated financial statements of AGCO Corporation and its subsidiaries (the “Company” or “AGCO”) included herein have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to present fairly the Company’s financial position, results of operations, comprehensive income and cash flows at the dates and for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Results for interim periods are not necessarily indicative of the results for the year. Certain prior period amounts have been reclassified to conform to the current period presentation.
The Company has a wholly-owned subsidiary in Turkey that distributes agricultural equipment and replacement parts within Turkey. On the basis of currently available data related to inflation indices and as a result of the devaluation of the Turkish lira relative to the United States dollar, the Turkish economy was determined to be highly inflationary. A highly inflationary economy is one where the cumulative inflation rate for the three years preceding the beginning of the reporting period, including interim reporting periods, is in excess of 100 percent. For the three months ended March 31, 2023, the Company's wholly-owned subsidiary in Turkey had net sales of approximately $114.2 million and total assets of approximately $172.5 million as of March 31, 2023. The monetary assets and liabilities denominated in the Turkish lira were approximately 2.8 billion Turkish lira (or approximately $146.7 million) and approximately 2.3 billion Turkish lira (or approximately $122.8 million), respectively, as of March 31, 2023. The monetary assets and liabilities were remeasured based on current published exchange rates.
The Company is subject to the risk of the imposition of limitations by governments on international transfers of funds.
For example, in recent years, the Argentine government has substantially limited the ability of companies to transfer funds out of Argentina. As a consequence of these limitations, the spread between the official government exchange rate and the exchange rates resulting implicitly from certain capital market operations, usually effected to obtain U.S. dollars, has broadened significantly. The Company has a wholly-owned subsidiary in Argentina that assembles and distributes agricultural equipment and replacement parts within Argentina. The net monetary assets of the Company’s operations in Argentina denominated in pesos at the official government rate were approximately 3.9 billion pesos (or approximately $18.5 million) as of March 31, 2023, inclusive of approximately 6.7 billion pesos (or approximately $32.0 million) in cash and cash equivalents. In addition, the Company has an obligation to reimburse AGCO Capital Argentina S.A., one of its finance joint ventures with Rabobank, up to $10 million under a guarantee related to the ability of AGCO Capital Argentina S.A. to transfer funds out of Argentina. The finance joint venture in Argentina has net monetary assets denominated in pesos at the official government rate of approximately 5.2 billion (or approximately $24.8 million) as of March 31, 2023, of which a majority is cash and cash equivalents. Future impairments and charges are possible in connection with these exposures.
The Company cannot predict the future impact of the COVID-19 pandemic on its business, including any related impacts on the global economic and political environments, market demand for its products, supply chain disruptions, possible workforce unavailability, exchange rates, commodity prices and availability of financing, and their impact to the Company’s net sales, production volumes, costs and overall financial conditions.
Recent Accounting Pronouncements
In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires measurement and recognition of expected versus incurred credit losses for financial assets. In November 2019, the FASB issued ASU 2019-10, “Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates,” which delays the effective date of ASU 2016-13 for smaller reporting companies and other non-SEC reporting entities. This applies to the Company’s equity method finance joint ventures, which were required to adopt ASU 2016-13 for annual periods beginning after December 15, 2022 and interim periods within those annual periods. The standard, and its subsequent modification, impacts the results of operations and financial condition of the Company’s finance joint ventures. For the
7

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
adoption of the standard by the Company’s finance joint ventures on January 1, 2023 under the modified retrospective approach, the Company recognized the cumulative effect of ASU 2016-13 as an adjustment to the opening balance of stockholders’ equity as of January 1, 2023 within “Retained earnings.” The cumulative effect was approximately $5.5 million.
In September 2022, the FASB issued ASU 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” The new standard requires that a buyer in a supplier finance program disclose sufficient information about the key terms of the program, the amount of outstanding confirmed obligations at period end, where the obligations are presented in the balance sheet, and a rollforward of the obligations during the annual period. This guidance was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the rollforward, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The adoption of ASU 2022-04 resulted in disclosure of the Company's supplier financing programs. Refer to Note 10 for further details.
The Company has adopted ASU 2021-08, “Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” effective for fiscal years beginning after December 15, 2022, which did not have a material impact on the Company's results of operations, financial condition or cash flows but is dependent on future acquisitions.
2. ACQUISITIONS
On May 2, 2022, the Company acquired JCA Industries, Inc. (“JCA”) for 63.0 million Canadian dollars (or approximately $49.2 million as of May 2, 2022). JCA is located in Winnipeg, Manitoba, Canada, and specializes in the design of electronic systems and software development to automate and control agricultural equipment. The Company allocated the purchase price to the assets acquired and liabilities assumed based on preliminary estimates of their fair values as of the acquisition date. The acquired net assets primarily consisted of accounts receivable, inventories, other current and noncurrent assets, accounts payable, accrued expenses, other current and noncurrent liabilities, property, plant and equipment, deferred tax liabilities as well as customer relationship, technology and trademark identifiable intangible assets. The Company recorded approximately 43.9 million Canadian dollars (or approximately $34.0 million) of goodwill associated with the acquisition. The results of operations of JCA have been included in the Company’s Condensed Consolidated Financial Statements as of and from the date of acquisition. The associated goodwill has been included in the Company’s North America geographical reportable segment. Proforma financial information related to the acquisition of JCA was not material to the Company’s results of operations.
On January 1, 2022, the Company acquired Appareo Systems, LLC (“Appareo”) for approximately $62.1 million, net of approximately $0.5 million of cash. As a result of the acquisition of the remaining 50% interest in IAS, the Company's previous operating joint venture with Appareo, the Company recorded a gain of approximately $3.4 million on the remeasurement of the previously held equity interest within “Other expense, net” in the Company's Condensed Consolidated Statements of Operations. The fair value of the previously held 50% interest in the joint venture as of the acquisition date was approximately $11.2 million. Appareo is headquartered in Fargo, North Dakota and offers engineering, manufacturing, and technology for end-to-end product development. The Company allocated the purchase price to the assets acquired and liabilities assumed based on preliminary estimates of their fair values as of the acquisition date. The acquired net assets primarily consisted of accounts receivable, inventories, other current and noncurrent assets, assets held for sale, lease right-of-use assets and liabilities, accounts payable, accrued expenses, other current and noncurrent liabilities, property, plant and equipment, as well as customer relationship, technology, non-competition agreements and trademark identifiable intangible assets. The Company recorded approximately $25.8 million of goodwill associated with the acquisition. The results of operations of Appareo have been included in the Company’s Condensed Consolidated Financial Statements as of and from the date of acquisition. The associated goodwill has been included in the Company’s North America geographical reportable segment. Proforma financial information related to the acquisition of Appareo was not material to the Company’s results of operations.
8

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
The acquired identifiable intangible assets of JCA and Appareo as of the date of their respective acquisitions during 2022 are summarized in the following table (in millions):

Intangible Asset |  | Amount |  | Weighted-Average Useful Life
Customer relationships |  | $ | 15.4 |  |  | 10 years
Technology |  | 15.4 |  | 8 years
Trademarks |  | 5.7 |  | 10 years
Non-competition agreements |  | 1.4 |  |  | 5 years
|  | $ | 37.9 |  |  |

3. RESTRUCTURING EXPENSES AND IMPAIRMENT CHARGES
Restructuring Expenses
In recent years, the Company has announced and initiated several actions to rationalize employee headcount in various manufacturing facilities and administrative offices located in the U.S., Europe, South America, Africa and China as well as the rationalization of its grain and protein business, in order to reduce costs in response to fluctuating global market demand. Restructuring expenses activity, which relates solely to employee severance, during the three months ended March 31, 2023 is summarized as follows (in millions):

Balance as of December 31, 2022 |  |  | $ | 6.8 |  |  |  |  |  |  |
First quarter 2023 provision |  |  | 1.4 |  |  |  |  |  |  |
First quarter 2023 cash activity |  |  | (1.0) |  |  |  |  |  |  |
Balance as of March 31, 2023 |  |  | $ | 7.2 |  |  |  |  |  |  |

Impairment Charges
As a consequence of the conflict between Russia and Ukraine, during the three months ended March 31, 2022, the Company assessed the fair value of its gross assets related to the joint ventures operating in Russia for potential impairment and recorded asset impairment charges of approximately $36.0 million, reflected as “Impairment charges” in its Condensed Consolidated Statements of Operations, with an offsetting benefit of approximately $12.2 million included within “Net income attributable to noncontrolling interests.” The Company sold its interest in its Russian distribution joint venture during the three months ended December 31, 2022. In addition, during the three months ended March 31, 2022, the Company recorded a write-down of its investment in its Russian finance joint venture of approximately $4.8 million, reflected within “Equity in net earnings of affiliates” in its Condensed Consolidated Statements of Operations. The Russian finance joint venture was sold during the three months ended December 31, 2022.
4. STOCK COMPENSATION PLANS
The Company recorded stock compensation expense as follows for the three months ended March 31, 2023 and 2022 (in millions):

|  | Three Months Ended March 31, |  |
|  | 2023 |  | 2022 |  |  |  |
Cost of goods sold |  | $ | 0.5 |  |  | $ | 0.3 |  |  |  |  |
Selling, general and administrative expenses |  | 13.5 |  |  | 6.7 |  |  |  |  |
Total stock compensation expense |  | $ | 14.0 |  |  | $ | 7.0 |  |  |  |  |

Stock Incentive Plan
Under the Company’s Long-Term Incentive Plan (the “Plan”), up to 10,000,000 shares of AGCO common stock may be issued. As of March 31, 2023, of the 10,000,000 shares reserved for issuance under the Plan, 3,586,952 shares were available
9

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
for grant, assuming the maximum number of shares are earned related to the performance award grants discussed below. The Plan allows the Company, under the direction of the Board of Directors’ Talent and Compensation Committee, to make grants of performance shares, stock appreciation rights, restricted stock units and restricted stock awards to employees, officers and non-employee directors of the Company.
Long-Term Incentive Plan and Related Performance Awards
The weighted average grant-date fair value of performance awards granted under the Plan during the three months ended March 31, 2023 and 2022 was $144.24 and $124.12, respectively.
During the three months ended March 31, 2023, the Company granted 279,724 performance awards related to varying performance periods. The compensation expense associated with all awards granted under the Plan is amortized ratably over the vesting or performance period based on the Company’s projected assessment of the level of performance that will be achieved.
Performance award transactions during the three months ended March 31, 2023 are presented as if the Company were to achieve its maximum levels of performance and assume the 2023 and 2022 performance awards subject to the total shareholder return modifier are achieved at target levels under the plan awards and were as follows:

Shares awarded but not earned at January 1 | 543,904 |
Shares awarded | 279,724 |
Shares forfeited | (13,018) |
Shares vested | — |
Shares awarded but not earned at March 31 | 810,610 |

As of March 31, 2023, the total compensation cost related to unearned performance awards not yet recognized, assuming the Company’s current projected assessment of the level of performance that will be achieved, was approximately $65.0 million, and the weighted average period over which it is expected to be recognized is approximately two years. The compensation cost not yet recognized could be higher or lower based on actual achieved levels of performance.
Restricted Stock Unit Awards
The weighted average grant-date fair value of the restricted stock units (“RSUs”) granted under the Plan during the three months ended March 31, 2023 and 2022 was $135.53 and $117.08, respectively.
During the three months ended March 31, 2023, the Company granted 100,835 RSU awards. RSUs granted in 2023, 2022 and 2021 entitle the participant to receive one share of the Company’s common stock for each RSU granted and vest one-third per year over a three-year requisite service period. The 2020 grant of RSU’s to certain executives has a three-year cliff vesting requirement subject to adjustment based on a total shareholder return modifier relative to the Company's defined peer group. The compensation expense associated with these awards is being amortized ratably over the requisite service period for the awards that are expected to vest.
RSU transactions during the three months ended March 31, 2023 assume the 2020 RSUs subject to the total shareholder return modifier are achieved at target levels, and were as follows:

RSUs awarded but not vested at January 1 | 213,198 |
RSUs awarded | 100,835 |
RSUs forfeited | (4,563) |
RSUs vested | (96,176) |
RSUs awarded but not vested at March 31 | 213,294 |

As of March 31, 2023, the total compensation cost related to the unvested RSUs not yet recognized was approximately $23.4 million, and the weighted average period over which it is expected to be recognized is approximately one and one-half years.
10

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Stock-Settled Appreciation Rights (“SSARs”)
Certain executives and key managers were eligible to receive grants of SSARs through the year ended December 31, 2020. The Company did not grant any SSARs since the year ended December 31, 2020 and does not currently anticipate granting any SSARs in the future.There were 102,009 SSARs outstanding as of March 31, 2023. As of March 31, 2023, the total compensation cost related to the unvested SSARs not yet recognized was approximately $0.2 million, and the weighted average period over which it is expected to be recognized is approximately one year.
Director Restricted Stock Grants
The Plan provides for annual restricted stock grants of the Company’s common stock to all non-employee directors. The 2023 grant was made on April 27, 2023 and equated to 12,069 shares of common stock, of which 10,524 shares of common stock were issued after shares were withheld for taxes. The Company recorded stock compensation expense of approximately $1.5 million in April 2023 associated with these grants.
5. GOODWILL AND OTHER INTANGIBLE ASSETS
Changes in the carrying amount of goodwill during the three months ended March 31, 2023 are summarized as follows (in millions):

| North America |  | South America |  | Europe/Middle East |  | Asia/Pacific/Africa |  | Consolidated
Balance as of December 31, 2022 | $ | 667.3 |  |  | $ | 86.0 |  |  | $ | 444.3 |  |  | $ | 113.2 |  |  | $ | 1,310.8 |
Foreign currency translation | — |  |  | 3.3 |  |  | 7.4 |  |  | 1.0 |  |  | 11.7 |
Balance as of March 31, 2023 | $ | 667.3 |  |  | $ | 89.3 |  |  | $ | 451.7 |  |  | $ | 114.2 |  |  | $ | 1,322.5 |

Goodwill is tested for impairment on an annual basis and more often if indications of impairment exist. The Company conducts its annual impairment analyses as of October 1 each fiscal year.
11

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Changes in the carrying amount of acquired intangible assets during the three months ended March 31, 2023 are summarized as follows (in millions):

Gross carrying amounts: | Trademarks and Tradenames |  | Customer Relationships |  | Patents and Technology |  | Land Use Rights |  | Total
Balance as of December 31, 2022 | $ | 191.8 |  |  | $ | 574.5 |  |  | $ | 150.6 |  |  | $ | 6.5 |  |  | $ | 923.4 |
Foreign currency translation | 1.3 |  |  | 3.3 |  |  | 1.4 |  |  | — |  |  | 6.0 |
Balance as of March 31, 2023 | $ | 193.1 |  |  | $ | 577.8 |  |  | $ | 152.0 |  |  | $ | 6.5 |  |  | $ | 929.4 |

Accumulated amortization: | Trademarks and Tradenames |  | Customer Relationships |  | Patents and Technology |  | Land Use Rights |  | Total
Balance as of December 31, 2022 | $ | 103.3 |  |  | $ | 440.8 |  |  | $ | 101.5 |  |  | $ | 1.6 |  |  | $ | 647.2 |
Amortization expense | 2.5 |  |  | 9.6 |  |  | 2.7 |  |  | — |  |  | 14.8 |
Foreign currency translation | 0.6 |  |  | 3.0 |  |  | 1.0 |  |  | — |  |  | 4.6 |
Balance as of March 31, 2023 | $ | 106.4 |  |  | $ | 453.4 |  |  | $ | 105.2 |  |  | $ | 1.6 |  |  | $ | 666.6 |

Indefinite-lived intangible assets: | Trademarks and Tradenames
Balance as of December 31, 2022 | $ | 84.8 |
Foreign currency translation | 0.6 |
Balance as of March 31, 2023 | $ | 85.4 |

The Company amortizes certain acquired identifiable intangible assets primarily on a straight-line basis over their estimated useful lives, which range from four to 50 years. External-use software, net, developed by the Company and marketed externally, was approximately $5.8 million as of March 31, 2023 and classified within “Intangible assets, net.” Amortization costs of external-use software was approximately $0.8 million as of March 31, 2023 and classified within “Cost of goods sold.”
6. INDEBTEDNESS
Long-term debt consisted of the following at March 31, 2023 and December 31, 2022 (in millions):

| March 31, 2023 |  | December 31, 2022
Credit facility, expires 2027 | $ | 706.2 |  |  | $ | 200.0 |
1.002% Senior term loan due 2025 | 272.3 |  |  | 267.3 |
Senior term loans due between 2023 and 2028 | 348.0 |  |  | 341.6 |
0.800% Senior notes due 2028 | 653.5 |  |  | 641.5 |
Other long-term debt | 5.2 |  |  | 5.1 |
Debt issuance costs | (3.5) |  |  | (3.6) |
| 1,981.7 |  |  | 1,451.9 |
Senior term loans due 2023, net of debt issuance costs | (188.4) |  |  | (184.9) |
Current portion of other long-term debt | (2.2) |  |  | (2.2) |
Total long-term indebtedness, less current portion | $ | 1,791.1 |  |  | $ | 1,264.8 |

Credit Facility
In December 2022, the Company, certain of its subsidiaries and Rabobank, and other named lenders entered into an amendment to its credit facility providing for a $1.25 billion multi-currency unsecured revolving credit facility (“credit facility”), which replaced the Company’s former $800.0 million multi-currency unsecured revolving credit facility. The amendment provided an additional $450.0 million in borrowing capacity. An initial borrowing under the credit facility was used to repay and retire a $240.0 million short-term multi-currency revolving credit facility with Rabobank that was due to mature on
12

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
March 31, 2023. The credit facility consists of a $325.0 million U.S. dollar tranche and a $925.0 million multi-currency tranche for loans denominated in U.S. Dollars, Euros or other currencies to be agreed upon. The credit facility matures on December 19, 2027. Interest accrues on amounts outstanding for any borrowings denominated in U.S. dollars, at the Company’s option, at either (1) the Secured Overnight Financing Rate (“SOFR”) plus 0.1% plus a margin ranging from 0.875% to 1.875% based on the Company’s credit rating, or (2) the base rate, which is the highest of (i) the Prime Rate, (ii) the Federal Funds Effective Rate plus 0.5%, and (iii) Term SOFR for a one-month tenor plus 1.0%, plus a margin ranging from 0.000% to 0.875% based on the Company’s credit rating. Interest accrues on amounts outstanding for any borrowings denominated in Euros at the Euro Interbank Offered Rate (“EURIBOR”) plus a margin ranging from 0.875% to 1.875% based on the Company’s credit rating. As of March 31, 2023, the Company had $706.2 million outstanding borrowings under the revolving credit facility and had the ability to borrow $543.8 million.
Uncommitted Credit Facility
In June 2022, the Company entered into an uncommitted revolving credit facility that allows the Company to borrow up to €100.0 million (or approximately $108.9 million as of March 31, 2023). The credit facility expires on December 31, 2026. Any loans will bear interest at the EURIBOR plus a credit spread. As of March 31, 2023, the Company had no outstanding borrowings under the revolving credit facility and had the ability to borrow €100.0 million (or approximately $108.9 million).
0.800% Senior Notes Due 2028
On October 6, 2021, the Company issued €600.0 million (or approximately $653.5 million as of March 31, 2023) of senior notes at an issue price of 99.993%. The notes mature on October 6, 2028, and interest is payable annually, in arrears, at 0.800%. The notes contain covenants restricting, among other things, the incurrence of certain secured indebtedness. The senior notes are subject to both optional and mandatory redemption in certain events.
1.002% Senior Term Loan Due 2025
On January 25, 2019, the Company borrowed €250.0 million (or approximately $272.3 million as of March 31, 2023) from the European Investment Bank. The loan matures on January 24, 2025. The Company is permitted to prepay the loan before its maturity date. Interest is payable on the loan at 1.002% per annum, payable semi-annually in arrears.
Senior Term Loans Due Between 2023 and 2028
In October 2016, the Company borrowed an aggregate amount of €375.0 million through a group of seven related term loan agreements, and in August 2018, the Company borrowed an additional aggregate amount of €338.0 million through a group of another seven related term loan agreements. Of the 2016 term loans, the Company repaid an aggregate amount of €249.0 million in October 2019, October 2021 and April 2022. Of the 2018 senior term loans, the Company repaid an aggregate amount of €144.5 million in August 2021 and February 2022.
In aggregate, as of March 31, 2023, the Company had indebtedness of €319.5 million (or approximately $348.0 million as of March 31, 2023) through a group of six remaining related term loan agreements. Two of the term loan agreements in the aggregate amount of €173.0 million (or approximately $188.4 million net of debt issuance costs, as of March 31, 2023) will mature in August and October 2023. The provisions of the term loan agreements are substantially identical, with the exception of interest rate terms and maturities. As of March 31, 2023, for the term loans with a fixed interest rate, interest is payable in arrears on an annual basis, with interest rates ranging from 1.20% to 2.26% and maturity dates between August 2023 and August 2028. For the term loan with a floating interest rate, interest is payable in arrears on a semi-annual basis, with an interest rate based on the EURIBOR plus a margin of 1.10% and a maturity date of August 2025.
Other Short-Term Borrowings
As of March 31, 2023 and December 31, 2022, the Company had short-term borrowings due within one year of approximately $4.9 million and $8.9 million, respectively.
Standby Letters of Credit and Similar Instruments
The Company has arrangements with various banks to issue standby letters of credit or similar instruments, which guarantee the Company’s obligations for the purchase or sale of certain inventories and for potential claims exposure for
13

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
insurance coverage. At March 31, 2023 and December 31, 2022, outstanding letters of credit totaled approximately $14.7 million and $14.4 million, respectively.
7. RECOVERABLE INDIRECT TAXES
The Company’s Brazilian operations incur value added taxes (“VAT”) on certain purchases of raw materials, components and services. These taxes are accumulated as tax credits and create assets that are reduced by the VAT collected from the Company’s sales in the Brazilian market. The Company regularly assesses the recoverability of these tax credits and establishes reserves when necessary against them, through analyses that include, amongst others, the history of realization, the transfer of tax credits to third parties as authorized by the government, anticipated changes in the supply chain and the future expectation of tax debits from the Company’s ongoing operations. The Company believes that these tax credits, net of established reserves, are realizable. The Company had recorded approximately $101.6 million and $94.6 million, respectively, of VAT tax credits, net of reserves, as of March 31, 2023 and December 31, 2022.
8. INVENTORIES
Inventories at March 31, 2023 and December 31, 2022 were as follows (in millions):

| March 31, 2023 |  | December 31, 2022
Finished goods | $ | 1,248.4 |  |  | $ | 994.9 |
Repair and replacement parts | 789.0 |  |  | 750.1 |
Work in process | 461.1 |  |  | 369.8 |
Raw materials | 1,144.3 |  |  | 1,074.9 |
Inventories, net | $ | 3,642.8 |  |  | $ | 3,189.7 |

9. PRODUCT WARRANTY
The warranty reserve activity for the three months ended March 31, 2023 and 2022, including deferred revenue associated with the Company's extended warranties that have been sold, was as follows (in millions):

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Balance at beginning of period | $ | 640.0 |  |  | $ | 592.5 |  |  |  |  |
Accruals for warranties issued during the period | 89.7 |  |  | 83.3 |  |  |  |  |
Settlements made (in cash or in kind) during the period | (64.5) |  |  | (57.7) |  |  |  |  |
Foreign currency translation | 11.8 |  |  | (3.6) |  |  |  |  |
Balance at March 31 | $ | 677.0 |  |  | $ | 614.5 |  |  |  |  |

The Company’s agricultural equipment products generally are warranted against defects in material and workmanship for a period of one to four years. The Company accrues for future warranty costs at the time of sale based on historical warranty experience. Approximately $572.1 million, $546.0 million and $519.6 million of warranty reserves are included in “Accrued expenses” in the Company’s Condensed Consolidated Balance Sheets as of March 31, 2023, December 31, 2022 and March 31, 2022, respectively. Approximately $104.9 million, $94.0 million and $94.9 million of warranty reserves are included in “Other noncurrent liabilities” in the Company’s Condensed Consolidated Balance Sheets as of March 31, 2023, December 31, 2022, and March 31, 2022, respectively.
The Company recognizes recoveries of the costs associated with warranties it provides when the collection is probable. When specifics of the recovery have been agreed upon with the Company’s suppliers through the confirmation of liability for the recovery, the Company records the recovery within “Accounts and notes receivable, net.” Estimates of the amount of warranty claim recoveries to be received from the Company’s suppliers based upon contractual supplier arrangements are recorded within “Other current assets.”
14

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
10. SUPPLIER FINANCE PROGRAMS
The Company has supplier financing arrangements with certain banks or other intermediaries whereby a bank or intermediary purchases receivables held by the Company’s suppliers. Under the program, suppliers have the option to be paid by the bank or intermediary earlier than the payment due date. When the supplier receives an early payment, they receive discounted amounts, and the Company pays the bank or intermediary the face amount of the invoice on the payment due date. The Company does not reimburse suppliers for any costs incurred for participation in the program. The Company and its suppliers agree on the contractual terms, including prices, quantities and payment terms, regardless of whether the supplier elects to participate in the supplier finance programs. The suppliers’ voluntary inclusion in the supplier financing programs has no bearing on the Company’s payment terms. The Company has no economic interest in a supplier’s decision to participate in the programs, and the Company has no direct financial relationship with the banks or other intermediaries as it relates to the supplier finance programs. As of March 31, 2023, payment terms with the majority of the Company’s suppliers are generally 30 to 180 days, which correspond to the contractual terms, with rates that are based on market rates (such as SOFR) plus a credit spread. There are no assets pledged as security under the programs. As of March 31, 2023, and December 31, 2022, the amount outstanding that remains unpaid to the banks or other intermediaries totaled $108.9 million and $121.5 million, respectively, and is reflected in “Accounts payable” in the Company’s Condensed Consolidated Balance Sheets.
11. NET INCOME PER COMMON SHARE
Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted net income per common share assumes the exercise of outstanding SSARs and the vesting of performance share awards and RSUs using the treasury stock method when there is no other circumstance other than the passage of time under which they would not be issued, and the effects of such assumptions are dilutive.
A reconciliation of net income attributable to AGCO Corporation and subsidiaries and weighted average common shares outstanding for purposes of calculating basic and diluted net income per share for the three months ended March 31, 2023 and 2022 is as follows (in millions, except per share data):

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Basic net income per share: |  |  |  |  |  |  |
Net income attributable to AGCO Corporation and subsidiaries | $ | 232.6 |  |  | $ | 151.8 |  |  |  |  |
Weighted average number of common shares outstanding | 74.9 |  |  | 74.6 |  |  |  |  |
Basic net income per share attributable to AGCO Corporation and subsidiaries | $ | 3.11 |  |  | $ | 2.03 |  |  |  |  |
Diluted net income per share: |  |  |  |  |  |  |
Net income attributable to AGCO Corporation and subsidiaries | $ | 232.6 |  |  | $ | 151.8 |  |  |  |  |
Weighted average number of common shares outstanding | 74.9 |  |  | 74.6 |  |  |  |  |
Dilutive SSARs, performance share awards and RSUs | 0.1 |  |  | 0.3 |  |  |  |  |
Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted net income per share | 75.0 |  |  | 74.9 |  |  |  |  |
Diluted net income per share attributable to AGCO Corporation and subsidiaries | $ | 3.10 |  |  | $ | 2.03 |  |  |  |  |

There were no SSARs outstanding for the three months ended March 31, 2023 and 2022 that had an antidilutive impact.
12. INCOME TAXES
At March 31, 2023 and December 31, 2022, the Company had approximately $301.9 million and $281.7 million, respectively, of gross unrecognized income tax benefits, all of which would affect the Company’s effective tax rate if recognized. Gross unrecognized income tax benefits as of March 31, 2023 and December 31, 2022 exclude certain indirect favorable effects that relate to other tax jurisdictions of approximately $80.9 million and $74.0 million, respectively. In addition, the gross unrecognized income tax benefits as of March 31, 2023 and December 31, 2022 exclude certain deposits made in a foreign jurisdiction of approximately $45.9 million and $45.1 million, respectively, associated with an ongoing audit. At March 31, 2023 and December 31, 2022, the Company had approximately $12.4 million and $10.4 million, respectively, of accrued or deferred taxes related to uncertain income tax positions connected with ongoing income tax audits in various jurisdictions that it expects to settle or pay in the next 12 months, reflected in “Other current liabilities” in the
15

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Company’s Condensed Consolidated Balance Sheets. At March 31, 2023 and December 31, 2022, the Company had approximately $292.4 million and $274.1 million, respectively, of accrued taxes reflected in “Other noncurrent liabilities”, and approximately $2.9 million and $2.8 million, respectively, of deferred tax assets related to uncertain tax positions that it expects to settle or pay beyond 12 months, reflected in “Deferred tax assets” in the Company’s Condensed Consolidated Balance Sheets. The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. At March 31, 2023 and December 31, 2022, the Company had accrued interest and penalties related to unrecognized tax benefits of approximately $27.7 million and $25.8 million, respectively. Generally, tax years 2017 through 2022 remain open to examination by taxing authorities in the United States and certain other foreign tax jurisdictions. The Company and its subsidiaries are routinely examined by tax authorities in the United States and in various state, local and foreign jurisdictions. As of March 31, 2023, a number of income tax examinations in foreign jurisdictions are ongoing.
The Company maintains a valuation allowance to fully reserve against its net deferred tax assets in certain foreign jurisdictions. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from estimated future taxable income and available tax planning strategies and has determined that all adjustments to the valuation allowances have been appropriate. In making this assessment, all available evidence was considered including the current economic climate, as well as reasonable tax planning strategies. The Company believes it is more likely than not that the Company will realize its remaining net deferred tax assets, net of the valuation allowance, in future years.
In 2008 and 2012, as part of routine audits, the Brazilian taxing authorities disallowed deductions relating to the amortization of certain goodwill recognized in connection with a reorganization of the Company’s Brazilian operations and the related transfer of certain assets to the Company’s Brazilian subsidiaries. The amount of the tax disallowance through March 31, 2023, not including interest and penalties, was approximately 131.5 million Brazilian reais (or approximately $25.8 million). The amount ultimately in dispute would be significantly greater because of interest and penalties. The Company has been historically and currently advised by its legal and tax advisors that its position with respect to the deductions is allowable under the tax laws of Brazil. The Company has been contesting the disallowance and has historically maintained that it is not likely that the assessment, interest or penalties would be required to be paid. The ultimate outcome of the case would not have been determined until the Brazilian tax appeal process was completed and the Company’s legal advisors have indicated that would likely take several years.
On January 12, 2023, the Brazilian government issued a “Litigation Zero” tax amnesty program, whereby cases being disputed at the administrative court level of review for a period of more than ten years can be considered for amnesty. If companies choose to enroll in the amnesty program, it would not be considered an admission of guilt with respect to outstanding cases. The amnesty program allows companies to settle outstanding contested cases at a significant monetary discount. After weighing various impacts involved with enrollment in the tax amnesty program, including potential interest, penalties and legal costs, the Company concluded that it would apply to enroll in the program prior to the quarter ended March 31, 2023. The Company recorded its best estimate of the ultimate settlement under the amnesty program of approximately $29.5 million within “Income tax provision” for the three months ended March 31, 2023, net of associated U.S. income tax credits. The Company paid an initial installment payment of 40.6 million Brazilian reais (or approximately $7.7 million) in March 2023 related to the enrollment.
13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Derivative Transactions Designated as Hedging Instruments
Cash Flow Hedges
Foreign Currency Contracts
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates. The changes in the fair values of these cash flow hedges are recorded in accumulated other comprehensive loss and are subsequently reclassified into “Cost of goods sold” during the period the sales and purchases are recognized. These amounts offset the effect of the changes in foreign currency rates on the related sale and purchase transactions.
During 2023 and 2022, the Company designated certain foreign currency contracts as cash flow hedges of expected future sales and purchases. The total notional value of derivatives that were designated as cash flow hedges was approximately $242.2 million and $364.8 million as of March 31, 2023 and December 31, 2022, respectively.
16

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Steel Commodity Contracts
During 2023 and 2022, the Company designated certain steel commodity contracts as cash flow hedges of expected future purchases of steel. The total notional value of derivatives that were designated as cash flow hedges was approximately $7.2 million and $0.9 million as of March 31, 2023 and December 31, 2022, respectively.
The following tables summarize the after-tax impact that changes in the fair value of derivatives designated as cash flow hedges had on accumulated other comprehensive loss and net income during the three months ended March 31, 2023 and 2022 (in millions):

|  |  | Recognized in Net Income
Three Months Ended March 31, | Gain (Loss) Recognized in Accumulated Other Comprehensive Loss |  | Classification of Gain (Loss) |  | Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income |  | Total Amount of the Line Item in the Condensed Consolidated Statements of Operations Containing Hedge Gains (Losses)
2023 |  |  |  |  |  |  |
Foreign currency contracts(1) | $ | (1.9) |  |  | Cost of goods sold |  | $ | (1.8) |  |  | $ | 2,478.6 |
Commodity contracts(2) | 0.9 |  |  | Cost of goods sold |  | 0.3 |  |  | $ | 2,478.6 |
Total | $ | (1.0) |  |  |  |  | $ | (1.5) |  |  |
2022 |  |  |  |  |  |  |
Foreign currency contracts | $ | (3.8) |  |  | Cost of goods sold |  | $ | (0.1) |  |  | $ | 2,054.4 |
Commodity contracts | 1.4 |  |  | Cost of goods sold |  | 1.0 |  |  | $ | 2,054.4 |
Total | $ | (2.4) |  |  |  |  | $ | 0.9 |  |  |

____________________________________
(1) The outstanding contracts as of March 31, 2023 range in maturity through December 2023.
(2) The outstanding contracts as of March 31, 2023 range in maturity through July 2023.
The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the three months ended March 31, 2023 (in millions):

|  | Before-Tax Amount |  | Income Tax |  | After-Tax Amount
Accumulated derivative net losses as of December 31, 2022 |  | $ | (1.0) |  |  | $ | (0.1) |  |  | $ | (0.9) |
Net changes in fair value of derivatives |  | (1.4) |  |  | (0.4) |  |  | (1.0) |
Net losses reclassified from accumulated other comprehensive loss into income |  | 1.8 |  |  | 0.3 |  |  | 1.5 |
Accumulated derivative net losses as of March 31, 2023 |  | $ | (0.6) |  |  | $ | (0.2) |  |  | $ | (0.4) |

As of March 31, 2023, approximately $0.5 million and $0.1 million of derivative realized net losses, before taxes, remain in accumulated other comprehensive loss related to foreign currency contracts and commodity contracts, respectively, associated with inventory that had not yet been sold.
Net Investment Hedges
The Company uses non-derivative and derivative instruments to hedge a portion of its net investment in foreign operations against adverse movements in exchange rates. For instruments that are designated as hedges of net investments in foreign operations, changes in the fair value of the derivative instruments are recorded in foreign currency translation adjustments, a component of accumulated other comprehensive loss, to offset changes in the value of the net investments being hedged. When the net investment in foreign operations is sold or substantially liquidates, the amounts recorded in accumulated other comprehensive loss are reclassified to earnings. To the extent foreign currency denominated debt is de-designated from a
17

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
net investment hedge relationship, changes in the value of the foreign currency denominated debt are recorded in earnings through the maturity date.
On January 29, 2021, the Company entered into a new cross currency swap contract as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. The cross currency swap has an expiration date of January 29, 2028. At maturity of the cross currency swap contract, the Company will deliver the notional amount of approximately €247.9 million (or approximately $270.0 million as of March 31, 2023) and will receive $300.0 million from the counterparties. The Company will receive quarterly interest payments from the counterparties based on a fixed interest rate until the maturity of the cross currency swap.
During the three months ended March 31, 2023, the Company designated €150.0 million (or approximately $163.4 million as of March 31, 2023) of its multi-currency revolving credit facility with a maturity date of May 25, 2023 as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment.
The following table summarizes the notional values of the instrument designated as a net investment hedge (in millions):

| Notional Amount as of
| March 31, 2023 |  | December 31, 2022
Cross currency swap contract | $ | 300.0 |  |  | $ | 300.0 |
Foreign currency denominated debt | 163.4 |  |  | — |

The following table summarizes the changes in the fair value of the cross currency swap contract designated as a net investment hedge during the three months ended March 31, 2023 and 2022 (in millions):

| Cross currency swap contract |  | Foreign currency denominated debt |  |  |  |  |  |
| Gain (Loss) Recognized in Accumulated Other Comprehensive Loss for the Three Months Ended |  | Gain Recognized in Accumulated Other Comprehensive Loss for the Three Months Ended |  |
| Before-Tax Amount |  | Income Tax |  | After-Tax Amount |  | Before-Tax Amount |  | Income Tax |  | After-Tax Amount |  |  |  |  |  |
March 31, 2023 | $ | (1.0) |  |  | $ | 0.2 |  |  | $ | (0.8) |  |  | $ | 0.9 |  |  | $ | — |  |  | $ | 0.9 |  |  |  |  |  |  |
March 31, 2022 | 4.2 |  |  | (1.1) |  |  | 3.1 |  |  | — |  |  | — |  |  | — |  |  |  |  |  |  |

Derivative Transactions Not Designated as Hedging Instruments
During 2023 and 2022, the Company entered into foreign currency contracts to economically hedge receivables and payables on the Company and its subsidiaries’ balance sheets that are denominated in foreign currencies other than the functional currency. These contracts were classified as non-designated derivative instruments. Gains and losses on such contracts are substantially offset by losses and gains on the remeasurement of the underlying asset or liability being hedged and are immediately recognized into earnings. As of March 31, 2023 and December 31, 2022, the Company had outstanding foreign currency contracts with a notional amount of approximately $3.9 billion and $3.7 billion, respectively.
The following table summarizes the impact that changes in the fair value of derivatives not designated as hedging instruments had on net income (in millions):

|  |  | Gain (Loss) Recognized in Net Income for the Three Months Ended |  |
| Classification of Gain (Loss) |  | March 31, 2023 |  | March 31, 2022 |  |  |  |
Foreign currency contracts | Other expense, net |  | $ | 11.2 |  |  | $ | (13.8) |  |  |  |  |

18

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
The table below sets forth the fair value of derivative instruments as of March 31, 2023 (in millions):

| Asset Derivatives as of March 31, 2023 |  | Liability Derivatives as of March 31, 2023
| Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
Derivative instruments designated as hedging instruments: |  |  |  |  |  |  |
Foreign currency contracts | Other current assets |  | $ | 3.0 |  |  | Other current liabilities |  | $ | 3.5 |
Commodity contracts | Other current assets |  | 1.0 |  |  | Other current liabilities |  | 0.5 |
Cross currency swap contract | Other noncurrent assets |  | 32.0 |  |  | Other noncurrent liabilities |  | — |
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |
Foreign currency contracts(1) | Other current assets |  | 7.8 |  |  | Other current liabilities |  | 14.6 |
Total derivative instruments |  |  | $ | 43.8 |  |  |  |  | $ | 18.6 |

__________________________________
(1) The outstanding contracts as of March 31, 2023 range in maturity through July 2023.
The table below sets forth the fair value of derivative instruments as of December 31, 2022 (in millions):

| Asset Derivatives as of December 31, 2022 |  | Liability Derivatives as of December 31, 2022
| Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
Derivative instruments designated as hedging instruments: |  |  |  |  |  |  |
Foreign currency contracts | Other current assets |  | $ | 1.3 |  |  | Other current liabilities |  | $ | 1.3 |
Commodity contracts | Other current assets |  | — |  |  | Other current liabilities |  | — |
Cross currency swap contract | Other noncurrent assets |  | 33.0 |  |  | Other noncurrent liabilities |  | — |
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |
Foreign currency contracts(1) | Other current assets |  | 6.6 |  |  | Other current liabilities |  | 39.1 |
Total derivative instruments |  |  | $ | 40.9 |  |  |  |  | $ | 40.4 |

___________________________________
(1) The outstanding contracts as of December 31, 2022 range in maturity through March 2023.
19

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
14. CHANGES IN STOCKHOLDERS’ EQUITY
The following tables set forth changes in stockholders’ equity attributed to AGCO Corporation and its subsidiaries and to noncontrolling interests for the three months ended March 31, 2023 and 2022 (in millions):

| Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interests |  | Total Stockholders’ Equity
Balance, December 31, 2022 | $ | 0.7 |  |  | $ | 30.2 |  |  | $ | 5,654.6 |  |  | $ | (1,803.1) |  |  | $ | 0.2 |  |  | $ | 3,882.6 |
Stock compensation | — |  |  | 14.0 |  |  | — |  |  | — |  |  | — |  |  | 14.0 |
Issuance of stock awards | — |  |  | (18.4) |  |  | — |  |  | — |  |  | — |  |  | (18.4) |
SSARs exercised | — |  |  | (1.1) |  |  | — |  |  | — |  |  | — |  |  | (1.1) |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Net income | — |  |  | — |  |  | 232.6 |  |  | — |  |  | — |  |  | 232.6 |
Other comprehensive income, net of reclassification adjustments: |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments | — |  |  | — |  |  | — |  |  | 44.4 |  |  | — |  |  | 44.4 |
Defined benefit pension plans, net of tax | — |  |  | — |  |  | — |  |  | 1.8 |  |  | — |  |  | 1.8 |
Deferred gains and losses on derivatives, net of tax | — |  |  | — |  |  | — |  |  | 0.5 |  |  | — |  |  | 0.5 |
Payment of dividends to stockholders | — |  |  | — |  |  | (18.0) |  |  | — |  |  | — |  |  | (18.0) |
Adoption of ASU 2016-13 by finance joint ventures | — |  |  | — |  |  | (5.5) |  |  | — |  |  | — |  |  | (5.5) |
Balance, March 31, 2023 | $ | 0.7 |  |  | $ | 24.7 |  |  | $ | 5,863.7 |  |  | $ | (1,756.4) |  |  | $ | 0.2 |  |  | $ | 4,132.9 |

| Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interests |  | Total Stockholders’ Equity
Balance, December 31, 2021 | $ | 0.7 |  |  | $ | 3.9 |  |  | $ | 5,182.2 |  |  | $ | (1,770.9) |  |  | $ | 27.9 |  |  | $ | 3,443.8 |
Stock compensation | — |  |  | 7.0 |  |  | — |  |  | — |  |  | — |  |  | 7.0 |
Issuance of stock awards | — |  |  | (7.0) |  |  | (12.9) |  |  | — |  |  | — |  |  | (19.9) |
SSARs exercised | — |  |  | (1.0) |  |  | — |  |  | — |  |  | — |  |  | (1.0) |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Net income | — |  |  | — |  |  | 151.8 |  |  | — |  |  | (14.8) |  |  | 137.0 |
Other comprehensive income, net of reclassification adjustments: |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments | — |  |  | — |  |  | — |  |  | 137.5 |  |  | 0.8 |  |  | 138.3 |
Defined benefit pension plans, net of tax | — |  |  | — |  |  | — |  |  | 1.7 |  |  | — |  |  | 1.7 |
Deferred gains and losses on derivatives, net of tax | — |  |  | — |  |  | — |  |  | (3.3) |  |  | — |  |  | (3.3) |
Payment of dividends to stockholders | — |  |  | — |  |  | (14.9) |  |  | — |  |  | — |  |  | (14.9) |
Distributions to noncontrolling interest | — |  |  | — |  |  | — |  |  | — |  |  | (13.8) |  |  | (13.8) |
Balance, March 31, 2022 | $ | 0.7 |  |  | $ | 2.9 |  |  | $ | 5,306.2 |  |  | $ | (1,635.0) |  |  | $ | 0.1 |  |  | $ | 3,674.9 |

20

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Total comprehensive income (loss) attributable to noncontrolling interests for the three months ended March 31, 2023 and 2022 was as follows (in millions):

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Net income (loss) | $ | — |  |  | $ | (14.8) |  |  |  |  |
Other comprehensive income: |  |  |  |  |  |  |
Foreign currency translation adjustments | — |  |  | 0.8 |  |  |  |  |
Total comprehensive income (loss) | $ | — |  |  | $ | (14.0) |  |  |  |  |

The following table sets forth changes in accumulated other comprehensive loss by component, net of tax, attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2023 (in millions):

| Defined Benefit Pension Plans |  | Deferred Net (Losses) Gains on Derivatives |  | Cumulative Translation Adjustment |  | Total
Accumulated other comprehensive loss, December 31, 2022 | $ | (231.2) |  |  | $ | (0.9) |  |  | $ | (1,571.0) |  |  | $ | (1,803.1) |
Other comprehensive income (loss) before reclassifications | — |  |  | (1.0) |  |  | 44.4 |  |  | 43.4 |
Net losses reclassified from accumulated other comprehensive loss | 1.8 |  |  | 1.5 |  |  | — |  |  | 3.3 |
Other comprehensive income, net of reclassification adjustments | 1.8 |  |  | 0.5 |  |  | 44.4 |  |  | 46.7 |
Accumulated other comprehensive loss, March 31, 2023 | $ | (229.4) |  |  | $ | (0.4) |  |  | $ | (1,526.6) |  |  | $ | (1,756.4) |

The following table sets forth reclassification adjustments out of accumulated other comprehensive loss by component attributed to AGCO Corporation and its subsidiaries for the three months ended March 31, 2023 and 2022 (in millions):

|  | Amount Reclassified from Accumulated Other Comprehensive Loss |  | Affected Line Item within the Condensed Consolidated Statements of Operations
Details about Accumulated Other Comprehensive Loss Components |  | Three Months Ended March 31, 2023(1) |  | Three Months Ended March 31, 2022(1) |
Derivatives: |  |  |  |  |  |
Net losses on foreign currency contracts |  | $ | 2.2 |  |  | $ | 0.1 |  |  | Cost of goods sold
Net gains on commodity contracts |  | (0.4) |  |  | (1.3) |  |  | Cost of goods sold
Reclassification before tax |  | 1.8 |  |  | (1.2) |  |  |
|  | (0.3) |  |  | 0.3 |  |  | Income tax provision
Reclassification net of tax |  | $ | 1.5 |  |  | $ | (0.9) |  |  |
Defined benefit pension plans: |  |  |  |  |  |
Amortization of net actuarial losses |  | $ | 2.0 |  |  | $ | 2.2 |  |  | Other expense, net(2)
Amortization of prior service cost |  | 0.4 |  |  | 0.2 |  |  | Other expense, net(2)
Reclassification before tax |  | 2.4 |  |  | 2.4 |  |  |
|  | (0.6) |  |  | (0.7) |  |  | Income tax provision
Reclassification net of tax |  | $ | 1.8 |  |  | $ | 1.7 |  |  |
Net losses reclassified from accumulated other comprehensive loss |  | $ | 3.3 |  |  | $ | 0.8 |  |  |

__________________________________
(1) Losses (gains) included within the Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, respectively.
(2) These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. See Note 16 for additional information on the Company’s defined benefit pension plans.
21

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)

Share Repurchase Program
In November 2021, the Company entered into an accelerated share repurchase (“ASR”) agreement with a financial institution to repurchase an aggregate of $60.0 million shares of its common stock. The Company received 393,733 shares in this transaction as of December 31, 2021. On January 19, 2022, the Company received an additional 113,824 shares upon final settlement of its November 2021 ASR agreement. All shares received under the ASR agreement were retired upon receipt, and the excess of the purchase price over par value per share was recorded to a combination of “Additional paid-in capital” and “Retained earnings” within the Company’s Condensed Consolidated Balance Sheets.
During the three months ended March 31, 2023, the Company did not purchase any shares directly or enter into any accelerated share repurchase agreements. As of March 31, 2023, the remaining amount authorized to be repurchased under board-approved share repurchase authorizations was approximately $110.0 million, which has no expiration date.
Dividends
On April 27, 2023, the Company's Board of Directors approved an increase to its quarterly dividend commencing in the second quarter of 2023 by 21% to $0.29 per common share and declared a special variable dividend of $5.00 per common share that is to be paid during the second quarter of 2023.
15. ACCOUNTS RECEIVABLE SALES AGREEMENTS
The Company has accounts receivable sales agreements that permit the sale, on an ongoing basis, of a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. As of March 31, 2023 and December 31, 2022, the cash received from receivables sold under the U.S., Canadian, European and Brazilian accounts receivable sales agreements was approximately $1.7 billion and $1.8 billion, respectively.
Under the terms of the accounts receivable sales agreements in North America, Europe and Brazil, the Company pays
an annual fee related to the servicing of the receivables sold. The Company also pays the respective AGCO Finance entities a subsidized interest payment with respect to the accounts receivable sales agreements, calculated based upon the interest rate charged by Rabobank to its affiliate, and such affiliate then lends to the AGCO Finance entities plus an agreed-upon margin. These fees are reflected within losses on the sales of receivables included within “Other expense, net” in the Company’s Consolidated Statements of Operations. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. The Company reviewed its accounting for the accounts receivable sales agreements and determined that these facilities should be accounted for as off-balance sheet transactions.
In addition, the Company sells certain trade receivables under factoring arrangements to other financial institutions around the world. As of March 31, 2023 and December 31, 2022, the cash received from these arrangements was approximately $233.3 million and $226.0 million, respectively.
Losses on sales of receivables associated with the accounts receivable sales agreements discussed above, reflected within “Other expense, net” in the Company’s Condensed Consolidated Statements of Operations, were approximately $28.5 million and $7.9 million for the three months ended March 31, 2023 and 2022, respectively.
The Company’s finance joint ventures in Europe, Brazil and Australia also provide wholesale financing directly to the Company’s dealers. The receivables associated with these arrangements are without recourse to the Company. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. As of March 31, 2023 and December 31, 2022, these finance joint ventures had approximately $108.3 million and $69.5 million, respectively, of outstanding accounts receivable associated with these arrangements. The Company accounts for these arrangements as off-balance sheet transactions.
In certain foreign countries, the Company invoices its finance joint ventures directly and the finance joint ventures retain a form of title to the goods delivered to dealers until the dealer makes payment so that the finance joint ventures can recover the goods in the event of dealer or end customer default on payment. This occurs as the laws of some foreign countries do not provide for a seller’s retention of a security interest in goods in the same manner as established in the United States Uniform Commercial Code. The only right the finance joint ventures retain with respect to the title are those enabling recovery of the goods in the event of customer default on payment. The dealer or distributor may not return equipment or replacement
22

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
parts to the Company while its contract with the finance joint venture is in force, and can only return the equipment to the retail finance joint venture with penalties that would generally not make it economically beneficial to do so.
16. PENSION AND POSTRETIREMENT BENEFIT PLANS
Net periodic pension and postretirement benefit cost for the Company’s defined pension and postretirement benefit plans for the three months ended March 31, 2023 and 2022 are set forth below (in millions):

|  | Three Months Ended March 31, |  |
Pension benefits |  | 2023 |  | 2022 |  |  |  |
Service cost |  | $ | 2.4 |  |  | $ | 3.3 |  |  |  |  |
Interest cost |  | 7.2 |  |  | 4.0 |  |  |  |  |
Expected return on plan assets |  | (7.2) |  |  | (4.6) |  |  |  |  |
Amortization of net actuarial losses |  | 2.0 |  |  | 2.2 |  |  |  |  |
Amortization of prior service cost |  | 0.3 |  |  | 0.1 |  |  |  |  |
Net periodic pension cost |  | $ | 4.7 |  |  | $ | 5.0 |  |  |  |  |

|  | Three Months Ended March 31, |  |
Postretirement benefits |  | 2023 |  | 2022 |  |  |  |
Service cost |  | $ | — |  |  | $ | 0.1 |  |  |  |  |
Interest cost |  | 0.3 |  |  | 0.2 |  |  |  |  |
Amortization of prior service cost |  | 0.1 |  |  | 0.1 |  |  |  |  |
Net periodic postretirement benefit cost |  | $ | 0.4 |  |  | $ | 0.4 |  |  |  |  |

The components of net periodic pension and postretirement benefits cost, other than the service cost component, are included in “Other expense, net” in the Company’s Condensed Consolidated Statements of Operations.
The following table summarizes the activity in accumulated other comprehensive loss related to the Company's defined pension and postretirement benefit plans during the three months ended March 31, 2023 (in millions):

| Before-Tax Amount |  | Income Tax |  | After-Tax Amount
Accumulated other comprehensive loss, December 31, 2022 | $ | (304.4) |  |  | $ | (73.2) |  |  | $ | (231.2) |
Amortization of prior service cost | 0.4 |  |  | 0.1 |  |  | 0.3 |
Amortization of net actuarial losses | 2.0 |  |  | 0.5 |  |  | 1.5 |
Accumulated other comprehensive loss as of March 31, 2023 | $ | (302.0) |  |  | $ | (72.6) |  |  | $ | (229.4) |

During the three months ended March 31, 2023, the Company made approximately $10.4 million of contributions to its defined pension benefit plans. The Company currently estimates its minimum contributions for 2023 to its defined pension benefit plans will aggregate approximately $33.8 million.
During the three months ended March 31, 2023, the Company made approximately $0.5 million of contributions to its postretirement health care and life insurance benefit plans. The Company currently estimates that it will make approximately $1.5 million of contributions to its postretirement health care and life insurance benefit plans during 2023.
23

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
17. FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company categorizes its assets and liabilities into one of three levels based on the assumptions used in valuing the asset or liability. Estimates of fair value for financial assets and liabilities are based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. In accordance with this guidance, fair value measurements are classified under the following hierarchy:
•Level 1 - Quoted prices in active markets for identical assets or liabilities.
•Level 2 - Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
•Level 3 - Model-derived valuations in which one or more significant inputs are unobservable.
The Company categorizes its pension plan assets into one of the three levels of the fair value hierarchy.
The Company enters into foreign currency, commodity and interest rate swap contracts. The fair values of the Company’s derivative instruments are determined using discounted cash flow valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these discounted cash flow valuation models for derivative instruments include the applicable exchange rates, forward rates or interest rates. Such models used for option contracts also use implied volatility. See Note 13 for additional information on the Company’s derivative instruments and hedging activities.
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 are summarized below (in millions):

| As of March 31, 2023
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Derivative assets | $ | — |  |  | $ | 43.8 |  |  | $ | — |  |  | $ | 43.8 |
Derivative liabilities | — |  |  | 18.6 |  |  | — |  |  | 18.6 |

| As of December 31, 2022
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Derivative assets | $ | — |  |  | $ | 40.9 |  |  | $ | — |  |  | $ | 40.9 |
Derivative liabilities | — |  |  | 40.4 |  |  | — |  |  | 40.4 |

The carrying amounts of long-term debt under the Company’s 1.002% senior term loan due 2025 and senior term loans due between 2023 and 2028 approximate fair value based on the borrowing rates currently available to the Company for loans with similar terms and average maturities. At March 31, 2023, the estimated fair value of the Company's 0.800% senior notes due 2028, based on listed market values, was approximately €497.5 million (or approximately $541.8 million as of March 31, 2023), compared to the carrying value of €600.0 million (or approximately $653.5 million as of March 31, 2023). See Note 6 for additional information on the Company’s long-term debt.
24

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
18. SEGMENT REPORTING
The Company’s four reportable segments distribute a full range of agricultural equipment and related replacement parts. The Company evaluates segment performance primarily based on income from operations. Sales for each segment are based on the location of the third-party customer. The Company’s selling, general and administrative expenses and engineering expenses are generally charged to each segment based on the region and division where the expenses are incurred. As a result, the components of income from operations for one segment may not be comparable to another segment. Segment results for the three months ended March 31, 2023 and 2022 and assets as of March 31, 2023 and December 31, 2022 based on the Company’s reportable segments are as follows (in millions):

Three Months Ended March 31, |  | North America |  | South America |  | Europe/Middle East |  | Asia/Pacific/Africa |  | Consolidated
2023 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 923.1 |  |  | $ | 503.8 |  |  | $ | 1,703.8 |  |  | $ | 202.8 |  |  | $ | 3,333.5 |
Income from operations |  | 102.1 |  |  | 99.5 |  |  | 239.4 |  |  | 18.1 |  |  | 459.1 |
Depreciation |  | 14.9 |  |  | 7.8 |  |  | 26.8 |  |  | 4.1 |  |  | 53.6 |
Capital expenditures |  | 37.3 |  |  | 20.3 |  |  | 67.0 |  |  | 0.7 |  |  | 125.3 |
2022 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 701.0 |  |  | $ | 356.4 |  |  | $ | 1,403.1 |  |  | $ | 225.2 |  |  | $ | 2,685.7 |
Income from operations |  | 54.8 |  |  | 46.1 |  |  | 162.3 |  |  | 34.0 |  |  | 297.2 |
Depreciation |  | 15.2 |  |  | 7.0 |  |  | 28.2 |  |  | 4.3 |  |  | 54.7 |
Capital expenditures |  | 15.7 |  |  | 10.0 |  |  | 39.2 |  |  | 1.4 |  |  | 66.3 |
Assets |  |  |  |  |  |  |  |  |  |
As of March 31, 2023 |  | $ | 1,957.8 |  |  | $ | 1,386.8 |  |  | $ | 2,898.0 |  |  | $ | 771.7 |  |  | $ | 7,014.3 |
As of December 31, 2022 |  | 1,790.3 |  |  | 1,259.8 |  |  | 2,475.6 |  |  | 650.5 |  |  | 6,176.2 |

A reconciliation from the segment information to the consolidated balances for income from operations and total assets is set forth below (in millions):

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Segment income from operations | $ | 459.1 |  |  | $ | 297.2 |  |  |  |  |
Impairment charges | — |  |  | (36.0) |  |  |  |  |
Corporate expenses | (42.1) |  |  | (32.2) |  |  |  |  |
Amortization of intangibles | (14.8) |  |  | (15.3) |  |  |  |  |
Stock compensation expense | (13.5) |  |  | (6.7) |  |  |  |  |
Restructuring expenses | (1.4) |  |  | (3.0) |  |  |  |  |
Consolidated income from operations | $ | 387.3 |  |  | $ | 204.0 |  |  |  |  |

| March 31, 2023 |  | December 31, 2022
Segment assets | $ | 7,014.3 |  |  | $ | 6,176.2 |
Cash, cash equivalents and restricted cash | 558.7 |  |  | 789.5 |
Investments in affiliates | 456.5 |  |  | 436.9 |
Deferred tax assets, other current and noncurrent assets | 1,105.6 |  |  | 1,025.9 |
Intangible assets, net | 354.0 |  |  | 364.4 |
Goodwill | 1,322.5 |  |  | 1,310.8 |
Consolidated total assets | $ | 10,811.6 |  |  | $ | 10,103.7 |

25

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
19. COMMITMENTS AND CONTINGENCIES
Off-Balance Sheet Arrangements
Guarantees
The Company maintains a remarketing agreement with its U.S. finance joint venture, AGCO Finance LLC, whereby the Company is obligated to repurchase up to $6.0 million of repossessed equipment each calendar year. The Company believes that any losses that it might incur on the resale of this equipment will not be material, due to the fair value of the underlying equipment.
At March 31, 2023, the Company has outstanding guarantees of indebtedness owed to related and third parties of approximately $30.3 million, primarily related to dealer and end-user financing of equipment. Such guarantees generally obligate the Company to repay outstanding finance obligations owed to financial institutions if dealers or end users default on such loans through 2028. Losses under such guarantees historically have been insignificant. In addition, the Company generally would expect to be able to recover a significant portion of the amounts paid under such guarantees from the sale of the underlying financed farm equipment, as the fair value of such equipment is expected to be sufficient to offset a substantial portion of the amounts paid. The Company also has obligations to guarantee indebtedness owed to certain of its finance joint ventures if dealers or end users default on loans. Losses under such guarantees historically have been insignificant, and the guarantees are not material. The Company believes the credit risk associated with these guarantees is not material.
In addition, at March 31, 2023, the Company had accrued approximately $16.7 million of outstanding guarantees of residual values that may be owed to its finance joint ventures in the United States and Canada due upon expiration of certain eligible operating leases between the finance joint ventures and end users. The maximum potential amount of future payments under these guarantees is approximately $190.4 million.
Leases
Lease payment amounts for operating and finance leases with remaining terms greater than one year as of March 31, 2023 and December 31, 2022 were as follows (in millions):

|  | March 31, 2023 |  | December 31, 2022
|  | Operating Leases(1) |  | Finance Leases |  | Operating Leases(1) |  | Finance Leases
2023 |  | $ | 36.6 |  |  | $ | 0.6 |  |  | $ | 47.8 |  |  | $ | 0.8 |
2024 |  | 38.2 |  |  | 0.6 |  |  | 36.6 |  |  | 0.6 |
2025 |  | 28.7 |  |  | 0.5 |  |  | 27.0 |  |  | 0.4 |
2026 |  | 20.4 |  |  | 0.3 |  |  | 19.1 |  |  | 0.2 |
2027 |  | 13.9 |  |  | 0.3 |  |  | 13.4 |  |  | 0.2 |
Thereafter |  | 51.4 |  |  | 5.8 |  |  | 51.2 |  |  | 6.0 |
Total lease payments |  | 189.2 |  |  | 8.1 |  |  | 195.1 |  |  | 8.2 |
Less: imputed interest(2) |  | (24.7) |  |  | (2.0) |  |  | (27.5) |  |  | (2.1) |
Present value of leased liabilities |  | $ | 164.5 |  |  | $ | 6.1 |  |  | $ | 167.6 |  |  | $ | 6.1 |

__________________________________
(1) Operating lease payments include options to extend or terminate at the Company's sole discretion, which are included in the determination of lease term when they are reasonably certain to be exercised.
(2) Calculated for each lease using either the implicit interest rate or the incremental borrowing rate when the implicit interest rate is not readily available.
Other
At March 31, 2023, the Company had outstanding designated and non-designated foreign exchange contracts with a gross notional amount of approximately $4,188.5 million. The outstanding contracts as of March 31, 2023 range in maturity
26

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
through December 2023. The Company also had outstanding designated steel commodity contracts with a gross notional amount of approximately $7.2 million that range in maturity through July 2023.
The Company sells a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. The Company also sells certain accounts receivable under factoring arrangements to financial institutions around the world. The Company accounts for the sale of such receivables as off-balance sheet transactions.
Contingencies
In 2008 and 2012, as part of routine audits, the Brazilian taxing authorities disallowed deductions relating to the amortization of certain goodwill recognized in connection with a reorganization of the Company’s Brazilian operations and the related transfer of certain assets to the Company’s Brazilian subsidiaries. The amount of the tax disallowance through March 31, 2023, not including interest and penalties, was approximately 131.5 million Brazilian reais (or approximately $25.8 million). The amount ultimately in dispute would be significantly greater because of interest and penalties. The Company has been historically and currently advised by its legal and tax advisors that its position with respect to the deductions is allowable under the tax laws of Brazil. The Company has been contesting the disallowance and has historically maintained that it is not likely that the assessment, interest or penalties would be required to be paid. The ultimate outcome of the case would not have been determined until the Brazilian tax appeal process was completed and the Company’s legal advisors have indicated that would likely take several years.
On January 12, 2023, the Brazilian government issued a “Litigation Zero” tax amnesty program, whereby cases being disputed at the administrative court level of review for a period of more than ten years can be considered for amnesty. If companies choose to enroll in the amnesty program, it would not be considered an admission of guilt with respect to outstanding cases. The amnesty program allows companies to settle outstanding contested cases at a significant monetary discount. After weighing various impacts involved with enrollment in the tax amnesty program, including potential interest, penalties and legal costs, the Company concluded that it would apply to enroll in the program prior to the quarter ended March 31, 2023. The Company recorded its best estimate of the ultimate settlement under the amnesty program of approximately $29.5 million within “Income tax provision” for the three months ended March 31, 2023, net of associated U.S. income tax credits. The Company paid an initial installment payment of 40.6 million Brazilian reais (or approximately $7.7 million) in March 2023 related to the enrollment.
During 2017, the Company purchased Precision Planting, which provides precision agricultural technology solutions. In 2018, Deere & Company (“Deere”) filed separate complaints in the U.S. District Court of Delaware against the Company and Precision Planting alleging that certain products of those entities infringed certain patents of Deere. The two complaints subsequently were consolidated into a single case, Case No. 1:18-cv-00827-CFC. In July 2022, the case was tried before a jury, which determined that the Company and Precision Planting had not infringed the Deere patents. Following customary post-trial procedures, the Court entered a judgement in the Company’s favor, and in April 2023 Deere filed a Notice of Appeal. The Company has an indemnity right under the purchase agreement related to the acquisition of Precision Planting from its previous owner. Pursuant to that right, the previous owner of Precision Planting currently is responsible for the litigation costs associated with the complaint and is obligated to reimburse AGCO for some or all of the damages in the event of an adverse outcome in the litigation.
The Company is a party to various other legal claims and actions incidental to its business. The Company believes that none of these claims or actions, either individually or in the aggregate, are material to its business or financial statements as a whole, including its results of operations and financial condition.
27

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
20. REVENUE
Contract Liabilities
Contract liabilities relate to the following: (1) unrecognized revenues where advance payment of consideration precedes the Company’s performance with respect to extended warranty and maintenance contracts and where the performance obligation is satisfied over time, (2) unrecognized revenues where advance payment of consideration precedes the Company’s performance with respect to certain grain storage and protein production systems and where the performance obligation is satisfied over time and (3) unrecognized revenues where advance payment of consideration precedes the Company’s performance with respect to technology services and where the performance obligation is satisfied over time.
Significant changes in the balance of contract liabilities for the three months ended March 31, 2023 and 2022 were as follows (in millions):

| Three Months Ended March 31,
| 2023 |  | 2022
Balance at beginning of period | $ | 239.0 |  |  | $ | 226.2 |
Advance consideration received | 58.5 |  |  | 43.0 |
Revenue recognized during the period for extended warranty contracts, maintenance services and technology services | (24.9) |  |  | (18.6) |
Revenue recognized during the period related to grain storage and protein production systems | (16.0) |  |  | (14.6) |
Foreign currency translation | 3.0 |  |  | (3.6) |
Balance at March 31 | $ | 259.6 |  |  | $ | 232.4 |

The contract liabilities are classified as either “Accrued expenses” or “Other current liabilities” and “Other noncurrent liabilities” in the Company’s Condensed Consolidated Balance Sheets. During the three months ended March 31, 2023, the Company recognized approximately $35.7 million of revenue that was recorded as a contract liability at the beginning of 2023. During the three months ended March 31, 2022, the Company recognized approximately $24.0 million of revenue that was recorded as a contract liability at the beginning of 2022.
Remaining Performance Obligations
The estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) as of March 31, 2023 are $86.6 million for the remainder of 2023, $75.2 million in 2024, $45.5 million in 2025, $22.2 million in 2026 and $11.5 million thereafter, and relate primarily to extended warranty contracts. The Company applied the practical expedient in ASU 2014-09 and has not disclosed information about remaining performance obligations that have original expected durations of 12 months or less.
28

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Disaggregated Revenue
Net sales for the three months ended March 31, 2023 disaggregated by primary geographical markets and major products consisted of the following (in millions):

|  | North America |  | South America(1) |  | Europe/Middle East(1) |  | Asia/Pacific/Africa |  | Consolidated
Primary geographical markets: |  |  |  |  |  |  |  |  |  |
United States |  | $ | 760.1 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 760.1 |
Canada |  | 127.9 |  |  | — |  |  | — |  |  | — |  |  | 127.9 |
Brazil |  |  |  | 425.4 |  |  |  |  |  |  | 425.4 |
Other South America |  | — |  |  | 73.7 |  |  | — |  |  | — |  |  | 73.7 |
Germany |  | — |  |  | — |  |  | 395.4 |  |  | — |  |  | 395.4 |
France |  | — |  |  | — |  |  | 301.4 |  |  | — |  |  | 301.4 |
United Kingdom and Ireland |  | — |  |  | — |  |  | 174.9 |  |  | — |  |  | 174.9 |
Finland and Scandinavia |  | — |  |  | — |  |  | 180.0 |  |  | — |  |  | 180.0 |
Italy |  |  |  |  |  | 92.2 |  |  |  |  | 92.2 |
Other Europe |  | — |  |  | — |  |  | 444.3 |  |  | — |  |  | 444.3 |
Middle East and Algeria |  | — |  |  | — |  |  | 115.6 |  |  | — |  |  | 115.6 |
Africa |  | — |  |  | — |  |  | — |  |  | 30.4 |  |  | 30.4 |
Asia |  | — |  |  | — |  |  | — |  |  | 86.7 |  |  | 86.7 |
Australia and New Zealand |  | — |  |  | — |  |  | — |  |  | 85.7 |  |  | 85.7 |
Mexico, Central America and Caribbean |  | 35.1 |  |  | 4.7 |  |  | — |  |  | — |  |  | 39.8 |
|  | $ | 923.1 |  |  | $ | 503.8 |  |  | $ | 1,703.8 |  |  | $ | 202.8 |  |  | $ | 3,333.5 |
Major products: |  |  |  |  |  |  |  |  |  |
Tractors |  | $ | 312.1 |  |  | $ | 283.0 |  |  | $ | 1,205.7 |  |  | $ | 107.2 |  |  | $ | 1,908.0 |
Replacement parts |  | 101.8 |  |  | 43.4 |  |  | 283.2 |  |  | 27.3 |  |  | 455.7 |
Grain storage and protein production systems |  | 147.1 |  |  | 40.7 |  |  | 34.1 |  |  | 34.0 |  |  | 255.9 |
Combines, application equipment and other machinery |  | 362.1 |  |  | 136.8 |  |  | 180.7 |  |  | 34.3 |  |  | 713.9 |
|  | $ | 923.1 |  |  | $ | 503.8 |  |  | $ | 1,703.8 |  |  | $ | 202.8 |  |  | $ | 3,333.5 |

____________________________________
(1) Rounding may impact the summation of amounts.
29

Table of Contents
Notes to Condensed Consolidated Financial Statements - Continued
(unaudited)
Net sales for the three months ended March 31, 2022 disaggregated by primary geographical markets and major products consisted of the following (in millions):

|  | North America |  | South America |  | Europe/Middle East(1) |  | Asia/Pacific/Africa |  | Consolidated(1)
Primary geographical markets: |  |  |  |  |  |  |  |  |  |
United States |  | $ | 570.3 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 570.3 |
Canada |  | 101.1 |  |  | — |  |  | — |  |  | — |  |  | 101.1 |
Brazil |  |  |  | 273.8 |  |  |  |  |  |  | 273.8 |
Other South America |  | — |  |  | 79.1 |  |  | — |  |  | — |  |  | 79.1 |
Germany |  | — |  |  | — |  |  | 317.2 |  |  | — |  |  | 317.2 |
France |  | — |  |  | — |  |  | 271.6 |  |  | — |  |  | 271.6 |
United Kingdom and Ireland |  | — |  |  | — |  |  | 145.4 |  |  | — |  |  | 145.4 |
Finland and Scandinavia |  | — |  |  | — |  |  | 197.0 |  |  | — |  |  | 197.0 |
Italy |  |  |  |  |  | 71.4 |  |  |  |  | 71.4 |
Other Europe |  | — |  |  | — |  |  | 367.2 |  |  | — |  |  | 367.2 |
Middle East and Algeria |  | — |  |  | — |  |  | 33.4 |  |  | — |  |  | 33.4 |
Africa |  | — |  |  | — |  |  | — |  |  | 36.0 |  |  | 36.0 |
Asia |  | — |  |  | — |  |  | — |  |  | 104.6 |  |  | 104.6 |
Australia and New Zealand |  | — |  |  | — |  |  | — |  |  | 84.6 |  |  | 84.6 |
Mexico, Central America and Caribbean |  | 29.6 |  |  | 3.5 |  |  | — |  |  | — |  |  | 33.1 |
|  | $ | 701.0 |  |  | $ | 356.4 |  |  | $ | 1,403.1 |  |  | $ | 225.2 |  |  | $ | 2,685.7 |
Major products: |  |  |  |  |  |  |  |  |  |
Tractors |  | $ | 251.9 |  |  | $ | 206.6 |  |  | $ | 915.1 |  |  | $ | 125.4 |  |  | $ | 1,499.0 |
Replacement parts |  | 94.6 |  |  | 38.2 |  |  | 286.1 |  |  | 26.7 |  |  | 445.6 |
Grain storage and protein production systems |  | 131.1 |  |  | 40.0 |  |  | 31.3 |  |  | 37.5 |  |  | 239.9 |
Combines, application equipment and other machinery |  | 223.4 |  |  | 71.6 |  |  | 170.6 |  |  | 35.6 |  |  | 501.2 |
|  | $ | 701.0 |  |  | $ | 356.4 |  |  | $ | 1,403.1 |  |  | $ | 225.2 |  |  | $ | 2,685.7 |

____________________________________
(1) Rounding may impact the summation of amounts.

30

Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
GENERAL
Our operations are subject to the cyclical nature of the agricultural industry. Sales of our equipment are affected by, among other things, changes in net cash farm income, farm land values, weather conditions, the demand for agricultural commodities, commodity prices and general economic conditions. We record sales when we sell equipment and replacement parts to our independent dealers, distributors and other customers. To the extent possible, we attempt to sell products to our dealers and distributors on a level basis throughout the year to reduce the effect of seasonal demands on manufacturing operations and to minimize our investment in inventories. However, retail sales by dealers to farmers are highly seasonal and largely are a function of the timing of the planting and harvesting seasons. As a result, our net sales historically have been the lowest in the first quarter and have increased in subsequent quarters.
The COVID-19 pandemic and other economic and geopolitical factors, including inflation and the conflict in Ukraine, continue to create volatility in the global economy, including the potential for energy shortages, employment disruptions, supply chain constraints and delays in deliveries, as well as logistics interruptions. These factors, along with increasing industrial demand, can have an adverse effect on production levels, particularly as a result of delays in the receipts of parts and components. Supply chain issues of particular concern include a wide range of parts and components, including semiconductors. We may continue to face supplier bottlenecks and delays in all regions as well as challenges with logistics, and we continue to work to mitigate the impact of these issues in order to meet end-market demand.
RESULTS OF OPERATIONS
For the three months ended March 31, 2023, we generated net income of approximately $232.6 million, or $3.10 per share, compared to approximately $151.8 million, or $2.03 per share, for the same period in 2022.
Net sales during the three months ended March 31, 2023 were approximately $3,333.5 million, which was approximately 24.1% higher than the same periods in 2022. This increase was primarily as a result of net sales growth in high horsepower tractors, combines, application equipment and Precision Ag products during the three months ended March 31, 2023 compared to the same period in 2022, inclusive of approximately 5.4% of unfavorable foreign currency translation. In addition, favorable pricing more than offset significant material and freight cost inflation. Regionally, net sales were higher in our Europe/Middle East, North America and South America for the three months ended March 31, 2023 compared to 2022, as discussed below.
Income from operations for the three months ended March 31, 2023 was approximately $387.3 million compared to approximately $204.0 million for the same period in 2022. This increase was primarily the result of higher net sales and production volumes, along with a richer sales mix and positive net pricing compared to the same period in 2022.
Regionally, income from operations in our Europe/Middle East region increased for the three months ended March 31, 2023 compared to the same period in 2022 due to higher net sales and production volumes and a favorable sales mix. In our North American region, income from operations increased for the three months ended March 31, 2023 compared to the same period in 2022 due to elevated net sales and production volumes, as well as positive net pricing and a richer sales mix. In our South American region, income from operations increased in the three months ended March 31, 2023 compared to the same period in 2022 due to the benefit of elevated net sales, as well as significant pricing realization and a favorable sales mix, particularly of high horsepower, higher margin tractors. In our Asia/Pacific/Africa (“APA”) region, income from operations decreased for the three months ended March 31, 2023 compared to the same period in 2022, primarily due to lower net sales and production volumes.
Industry Market Conditions
Agricultural commodity prices continue to support favorable farm fundamentals resulting in strong demand for larger agricultural equipment as farmers continue to replace aging machines. Farmer input costs have moderated from levels experienced during 2022, and easing supply chain constraints are enabling industry production to keep pace with strong market demand. Future demand for agricultural equipment will be influenced by farm income, which is a function of commodity and protein prices, crop yields and government support.
31

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
In North America, industry unit retail sales of utility and high horsepower tractors for the first three months of 2023 decreased approximately 3% compared to the same period in 2022. The decrease was driven by lower sales of smaller tractors, partially offset by increased sales of higher horsepower units. Industry unit retail sales of combines for the first three months of 2023 increased approximately 117% compared to the same period in 2022 due to supply chain constraints experienced in 2022.
In Western Europe, industry unit retail sales of tractors decreased approximately 3% for the first three months of 2023 compared to the same period in 2022. Farmer sentiment in the region continues to be negatively impacted by the conflict in Ukraine and input cost inflation. Industry unit retail sales of combines for the first three months of 2023 increased approximately 60% compared to the first three months of 2022 due to supply chain constraints experienced in 2022.
In South America, industry unit retail sales of tractors decreased approximately 3% for the first three months of 2023 compared to the same period in 2022. Industry unit retail sales of combines for the first three months of 2023 increased approximately 18% compared to the first three months of 2022. Healthy farm income, supportive exchange rates and continued expansion in planted acreage are driving increased investments in high tech farm equipment and resulting in an outlook of modest growth in the South American tractor industry in 2023 compared to elevated levels in the prior year.
STATEMENTS OF OPERATIONS
Net sales for the three months ended March 31, 2023 were approximately $3,333.5 million compared to approximately $2,685.7 million for the same period in 2022. The following tables set forth, for the three months ended March 31, 2023, the impacts to net sales of currency translation by geographical segment (in millions, except percentages):

| Three Months Ended March 31, |  | Change |  | Change Due to Currency Translation |  |
| 2023 |  | 2022 |  | $ |  | % |  | $ |  | % |  |  |  |
Europe/Middle East | $ | 1,703.8 |  |  | $ | 1,403.1 |  |  | $ | 300.7 |  |  | 21.4 | % |  | $ | (124.0) |  |  | (8.8) | % |  |  |  |
North America | 923.1 |  |  | 701.0 |  |  | 222.1 |  |  | 31.7 | % |  | (5.0) |  |  | (0.7) | % |  |  |  |
South America | 503.8 |  |  | 356.4 |  |  | 147.4 |  |  | 41.4 | % |  | (2.9) |  |  | (0.8) | % |  |  |  |
Asia/Pacific/Africa | 202.8 |  |  | 225.2 |  |  | (22.4) |  |  | (9.9) | % |  | (14.3) |  |  | (6.3) | % |  |  |  |
| $ | 3,333.5 |  |  | $ | 2,685.7 |  |  | $ | 647.8 |  |  | 24.1 | % |  | $ | (146.2) |  |  | (5.4) | % |  |  |  |

Regionally, net sales in our EME region were higher during the three months ended March 31, 2023 compared to the same period in 2022 primarily due to higher net sales of high horsepower tractors, utility tractors and Fuse Precision Ag products, as well as positive pricing impacts, partially offset by negative foreign currency translation. Net sales in North America increased during the three months ended March 31, 2023 compared to the same period in 2022 primarily related to higher net sales of high horsepower tractors, application equipment and combines, as well as positive pricing impacts to offset inflationary cost pressures. Net sales in South America increased during the three months ended March 31, 2023 compared to the same period in 2022, primarily as a result of higher net sales of tractors, combines and application equipment, as well as favorable pricing impacts. In our APA region, net sales decreased during the three months ended March 31, 2023 compared to the same period in 2022, primarily driven by delayed shipments from European factories partially offset by higher net sales in Australia and China.
We estimate our worldwide average price increase was approximately 11.7% during the three months ended March 31, 2023 compared to the same prior year period. Consolidated net sales of tractors and combines, which combined comprised approximately 61.9% of our net sales for the three months ended March 31, 2023, increased approximately 29.8% compared to the same period in 2022. Unit sales of tractors and combines increased approximately 3.5% for the three months ended March 31, 2023 compared to the same period in 2022. The difference between the unit sales change and the change in net sales was primarily the result of foreign currency translation, pricing and sales mix changes.
32

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
The following tables set forth, for the periods indicated, the percentage of net sales of certain items in our Condensed Consolidated Statements of Operations (in millions, except percentages):

|  | Three Months Ended March 31,
|  | 2023 |  | 2022
|  | $ |  | % of Net Sales(1) |  | $ |  | % of Net Sales
Gross profit |  | $ | 854.9 |  |  | 25.6 | % |  | $ | 631.3 |  |  | 23.5 | %
Selling, general and administrative expenses |  | 330.3 |  |  | 9.9 | % |  | 271.1 |  |  | 10.1 | %
Engineering expenses |  | 119.6 |  |  | 3.6 | % |  | 100.3 |  |  | 3.7 | %
Amortization of intangibles |  | 14.8 |  |  | 0.4 | % |  | 15.3 |  |  | 0.6 | %
Impairment charges |  | — |  |  | — | % |  | 36.0 |  |  | 1.3 | %
Restructuring expenses |  | 1.4 |  |  | — | % |  | 3.0 |  |  | 0.1 | %
Bad debt expense |  | 1.5 |  |  | — | % |  | 1.6 |  |  | 0.1 | %
Income from operations |  | $ | 387.3 |  |  | 11.6 | % |  | $ | 204.0 |  |  | 7.6 | %

____________________________________
(1) Rounding may impact the summation of amounts.
Gross profit as a percentage of net sales increased for the three months ended March 31, 2023 compared to the same period in 2022 primarily as a result of higher sales and production as well as favorable pricing that more than offset inflationary material and freight cost increases.
Global production hours increased approximately 8.2% in the three months ended March 31, 2023 compared to the same period in 2022. The increase was primarily due to higher market demand during the three months ended March 31, 2023, as well as easing of supply chain and logistics disruptions experienced in 2022. Some of our production facilities continue to face supply chain and logistics disruptions as well as material, labor and freight cost inflation. These disruptions have impacted our ability to produce and ship units, which also has contributed to labor inefficiencies and resulted in higher than anticipated raw material and work in process inventory levels. These factors may continue, which could impact production and inventory levels and net sales and margins in future periods.
We recorded approximately $0.5 million and $0.3 million of stock compensation expense within cost of goods sold during the three months ended March 31, 2023 and 2022, respectively. See below and refer to Note 4 to our Condensed Consolidated Financial Statements for additional information on stock compensation expense.
Selling, general and administrative expenses (“SG&A expenses”) as a percentage of net sales were lower for the three months ended March 31, 2023 compared to the same period in 2022 primarily due to higher net sales and foreign currency translation impacts. We recorded approximately $13.5 million of stock compensation expense within SG&A expenses during the three months ended March 31, 2023, compared to approximately $6.7 million during the same period in 2022. Refer to Note 4 to our Condensed Consolidated Financial Statements for additional information on stock compensation expense.
The restructuring expenses of approximately $1.4 million recorded during the three months ended March 31, 2023 primarily related to severance and other related costs associated with the rationalization of certain South American manufacturing operations. Refer to Note 3 to our Condensed Consolidated Financial Statements for additional information.
Interest expense, net was approximately $0.5 million for the three months ended March 31, 2023 compared to approximately $0.4 million for the comparable period in 2022, resulting primarily from increased interest rates and debt levels in 2023 compared to 2022. See “Liquidity and Capital Resources” for further information.
Other expense, net was approximately $50.4 million for the three months ended March 31, 2023 compared to approximately $17.5 million for the comparable period in 2022. Losses on sales of receivables, primarily related to our accounts receivable sales agreements with our finance joint ventures in North America, Europe and Brazil and included in “Other expense, net,” were approximately $28.5 million for the three months ended March 31, 2023 compared to approximately $7.9 million for the comparable period in 2022. This increase in losses for the three months ended March 31, 2023 was primarily a result of higher interest rates as compared to 2022.
33

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
We recorded an income tax provision of approximately $120.2 million for the three months ended March 31, 2023 compared to approximately $60.2 million for the comparable period in 2022. Our effective tax rate varies from period to period due to the mix of taxable income and losses in the various tax jurisdictions in which we operate. We maintain a valuation allowance to reserve against our net deferred tax assets in certain foreign jurisdictions. In addition, we recorded approximately $29.5 million within our income tax provision during the three months ended March 31, 2023 associated with our enrollment in a Brazilian tax amnesty program as is more fully described in Notes 12 and 19 of our Condensed Consolidated Financial Statements.
Equity in net earnings of affiliates, which is primarily comprised of income from our AGCO Finance joint ventures, was approximately $16.4 million for the three months ended March 31, 2023 compared to approximately $11.1 million for the comparable period in 2022. A write-down of our investment in our Russian finance joint venture of approximately $4.8 million was recorded during the three months ended March 31, 2022. The Russian finance joint venture was sold during the three months ended December 31, 2022. Refer to “Finance Joint Ventures” for further information regarding our finance joint ventures and their results of operations.
There was no loss or income attributable to noncontrolling interests during the three months ended March 31, 2023 compared to approximately $14.8 million of losses in the same period in 2022. The losses during 2022 related to our Russia joint venture.
We previously invested in two joint ventures that operated in Russia primarily for the manufacture and distribution of equipment and parts. Beginning in 2018, our Russian joint venture partner became subject to sanctions by the United States. Subsequent to the commencement of these sanctions, we previously had time-limited general licenses from the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of Treasury that permitted us to continue our participation, which expired on May 25, 2022. Following that expiration, we “blocked” our interest in our Russian manufacturing joint venture through a process acceptable to OFAC, which had the effect of suspending our role in that joint venture. During the three months ended March 31, 2022, we assessed the fair value of our gross assets related to the joint ventures for potential impairments and recorded asset impairment charges of approximately $36.0 million. During the three months ended December 31, 2022, we sold our interest in the Russian distribution joint venture. Refer to Note 3 of our Condensed Consolidated Financial Statements for additional information.
FINANCE JOINT VENTURES
Our AGCO Finance joint ventures provide both retail financing and wholesale financing to our dealers in the United States, Canada, Europe, Brazil, Argentina and Australia. The joint ventures are owned by AGCO and by a wholly-owned subsidiary of Rabobank. The majority of the assets of the finance joint ventures consist of finance receivables. The majority of the liabilities consist of notes payable and accrued interest. Under the various joint venture agreements, Rabobank or its affiliates provide financing to the finance joint ventures, primarily through lines of credit. We do not guarantee the debt obligations of the joint ventures. In the United States and Canada, we guarantee certain minimum residual values to those joint ventures upon expiration of certain eligible leases between the finance joint ventures and end users. See “Commitments, Off-Balance Sheet Arrangements and Contingencies” and Note 19 for additional information.
As of March 31, 2023, our investment in the finance joint ventures, which is included in “Investment in affiliates” on our Condensed Consolidated Balance Sheets, was approximately $408.5 million compared to $390.2 million as of December 31, 2022. The total finance portfolio in our finance joint ventures was approximately $12.1 billion and $11.8 billion as of March 31, 2023 and December 31, 2022, respectively. The total finance portfolio as of March 31, 2023 included approximately $9.8 billion of retail receivables and $2.3 billion of wholesale receivables from our dealers. The total finance portfolio as of December 31, 2022 included approximately $9.5 billion of retail receivables and $2.3 billion of wholesale receivables from our dealers. The wholesale receivables either were sold directly to AGCO Finance without recourse from our operating companies or AGCO Finance provided the financing directly to the dealers. During the three months ended March 31, 2023, we made no additional investments in our finance joint ventures and there were no dividends paid from our finance joint ventures. For the three months ended March 31, 2023, our share in the earnings of the finance joint ventures, included in “Equity in net earnings of affiliates” within our Condensed Consolidated Statements of Operations, was approximately $15.9 million compared to approximately $11.3 million for the same period in 2022. In addition, during the three months ended March 31, 2022, we recorded a write-down of our investment in our Russian finance joint venture of approximately $4.8 million, reflected within “Equity in net earnings of affiliates” in our Condensed Consolidated Statements of Operations. The Russian finance joint venture was sold during the three months ended December 31, 2022.
34

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
LIQUIDITY AND CAPITAL RESOURCES
Our financing requirements generally are subject to variations due to seasonal changes in inventory and receivable levels. Internally generated funds are supplemented when necessary from external sources, primarily our credit facilities and accounts receivable sales agreement facilities. We believe that the following facilities and available cash and internally generated funds, will be sufficient to support our working capital, capital expenditures and debt service requirements for the foreseeable future (in millions):

| March 31, 2023(1)
Credit facility, expires 2027 | $ | 706.2 |
1.002% Senior term loan due 2025 | 272.3 |
Senior term loans due between 2023 and 2028 | 348.0 |
0.800% Senior notes due 2028 | 653.5 |
Other long-term debt | 5.2 |

____________________________________
(1) The amounts above are gross of debt issuance costs of an aggregate amount of approximately $3.5 million.
In December 2022, we, certain of our subsidiaries and Rabobank, and other named lenders entered into an amendment to our credit facility providing for a $1.25 billion multi-currency unsecured revolving credit facility (“credit facility”), which replaced our former $800.0 million multi-currency unsecured revolving credit facility, which is discussed below. The amendment provided an additional $450.0 million in borrowing capacity. An initial borrowing under the credit facility was used to repay and retire a $240.0 million short-term multi-currency revolving credit facility with Rabobank that was due to mature on March 31, 2023. The credit facility consists of a $325.0 million U.S. dollar tranche and a $925.0 million multi-currency tranche for loans denominated in U.S. Dollars, Euros or other currencies to be agreed upon. The credit facility matures on December 19, 2027. Interest accrues on amounts outstanding for any borrowings denominated in U.S. dollars, at our option, at either (1) the Secured Overnight Financing Rate (“SOFR”) plus 0.1% plus a margin ranging from 0.875% to 1.875% based on our credit rating, or (2) the base rate, which is the highest of (i) the Prime Rate, (ii) the Federal Funds Effective Rate plus 0.5%, and (iii) Term SOFR for a one-month tenor plus 1.0%, plus a margin ranging from 0.000% to 0.875% based on our credit rating. Interest accrues on amounts outstanding for any borrowings denominated in Euros at the Euro Interbank Offered Rate (“EURIBOR”) plus a margin ranging from 0.875% to 1.875% based on our credit rating. As of March 31, 2023, we had approximately $706.2 million outstanding borrowings under the revolving credit facility and had the ability to borrow approximately $543.8 million.
In June 2022, we entered into an uncommitted revolving credit facility that allows us to borrow up to €100.0 million (or approximately $108.9 million as of March 31, 2023). The credit facility expires on December 31, 2026. Any loans will bear interest at the EURIBOR plus a credit spread. As of March 31, 2023, we had no outstanding borrowings under the revolving credit facility and had the ability to borrow €100.0 million (or approximately $108.9 million).
On October 6, 2021, we issued €600.0 million (or approximately $653.5 million as of March 31, 2023) of senior notes at an issue price of 99.993%. The notes mature on October 6, 2028, and interest is payable annually, in arrears, at 0.800%. The senior notes contain covenants restricting, among other things, the incurrence of certain secured indebtedness. The senior notes are subject to both optional and mandatory redemption in certain events.
On January 25, 2019, we borrowed €250.0 million (or approximately $272.3 million as of March 31, 2023) from the European Investment Bank. The loan matures on January 24, 2025. Interest is payable on the term loan at 1.002% per annum, payable semi-annually in arrears.
In October 2016, we borrowed an aggregate amount of €375.0 million through a group of seven related term loan agreements. These agreements had maturities ranging from October 2019 to October 2026. In August 2018, we borrowed an additional aggregate amount of indebtedness of €338.0 million through a group of another seven related term loan agreements. The provisions of the term loan agreements are identical in nature with the exception of interest rate terms and maturities. Of the 2016 term loans, we repaid an aggregate amount of €249.0 million in October 2019, October 2021 and April 2022. Of the 2018 senior term loans, we repaid an aggregate amount of €144.5 million in August 2021 and February 2022. In aggregate, as of March 31, 2023, we have indebtedness of approximately €319.5 million (or approximately $348.0 million) through a group of six remaining term loan agreements. Two of the term loan agreements in the aggregate amount of €173.0 million (or approximately $188.4 million net of debt issuance costs, as of March 31, 2023) will mature in August and October 2023. We
35

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
expect to pay the amounts that mature during 2023 either through refinancing them under a similar program or cash on hand or available to us through our revolving credit facility. As of March 31, 2023, for the term loans with a fixed interest rate, interest is payable in arrears on an annual basis, with interest rates ranging from 1.20% to 2.26% and maturity dates between August 2023 and August 2028. For the term loan with a floating interest rate, interest is payable in arrears on a semi-annual basis, with an interest rate based on the EURIBOR plus a margin of 1.10% and a maturity date of August 2025.
As of March 31, 2023 and December 31, 2022, we had other short-term borrowings due within one year of approximately $4.9 million and $8.9 million, respectively.
We are in compliance with the financial covenants contained in these facilities and expect to continue to maintain such compliance. Should we ever encounter difficulties, our historical relationship with our lenders has been strong, and we anticipate their continued long-term support of our business.
Our accounts receivable sales agreements in North America, Europe and Brazil permit the sale, on an ongoing basis, of a majority of our receivables to our U.S., Canadian, European and Brazilian finance joint ventures. The sales of all receivables are without recourse to us. We do not service the receivables after the sales occur, and we do not maintain any direct retained interest in the receivables. These agreements are accounted for as off-balance sheet transactions and have the effect of reducing accounts receivable and short-term liabilities by the same amount. As of March 31, 2023 and December 31, 2022, the cash received from receivables sold under the U.S., Canadian, European and Brazilian accounts receivable sales agreements was approximately $1.7 billion and $1.8 billion, respectively.
In addition, we sell certain trade receivables under factoring arrangements to other financial institutions around the world. As of March 31, 2023 and December 31, 2022, the cash received from these arrangements was approximately $233.3 million and $226.0 million, respectively.
Our finance joint ventures in Europe, Brazil and Australia also provide wholesale financing directly to our dealers. The receivables associated with these arrangements are also without recourse to us. As of March 31, 2023 and December 31, 2022, these finance joint ventures had approximately $108.3 million and $69.5 million, respectively, of outstanding accounts receivable associated with these arrangements. These arrangements are accounted for as off-balance sheet transactions. In addition, we sell certain trade receivables under factoring arrangements to other financial institutions around the world. These arrangements are also accounted for as off-balance sheet transactions.
In order to efficiently manage our liquidity, we generally pay vendors in accordance with negotiated terms. To enable vendors to obtain payment in advance of our payment due dates to them, we have established programs in certain markets with financial institutions under which the vendors have the option to be paid by the financial institutions earlier than the payment due dates. Should we not be able to negotiate extended payment terms with our vendors, or should financial institutions no longer be willing to participate in early payment programs with us, we would expect to have sufficient liquidity to timely pay our vendors without any material impact on us or our financial position. Refer to Note 10 of our Condensed Consolidated Financial Statements for further discussion.
Our debt to capitalization ratio, which is total indebtedness divided by the sum of total indebtedness and stockholders’ equity, was 32.5% and 29.7% at March 31, 2023 and December 31, 2022, respectively.
Cash Flows
Cash flows used in operating activities were approximately $557.1 million for the first three months of 2023 compared to cash flows used in operating activities of $576.5 million for the same period in 2022. Supply chain disruptions continue to result in higher raw material and work-in-process inventory levels during the first three months in 2023.
Our working capital requirements are seasonal, with investments in working capital typically building in the first half of the year and then reducing in the second half of the year. We had approximately $2,344.5 million in working capital at March 31, 2023 as compared to $1,651.3 million at December 31, 2022 and $2,201.8 million at March 31, 2022. Accounts receivable and inventories, combined, as of March 31, 2023 were approximately $762.5 million and $805.6 million higher, respectively, than at December 31, 2022 and March 31, 2022. Accounts receivable and inventories, combined, at March 31, 2023 were higher than at December 31, 2022 and March 31, 2022 primarily due to higher net sales and the lingering impact of supply chain constraints.
36

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
Capital expenditures for the first three months of 2023 were approximately $125.3 million compared to $66.3 million for the same period in 2022 primarily due to capital investments made in our smart farming and precision agriculture manufacturing capacity. We anticipate capital expenditures for the full year of 2023 will be approximately $375.0 million and will be used primarily to upgrade our system capabilities, improve our factory productivity, and to support the development and enhancement of new and existing products, including investments in smart farming, precision agriculture and digital technologies.
Share Repurchase and Dividends
During the three months ended March 31, 2023, we did not purchase any shares directly or enter into any accelerated share repurchase agreements. As of March 31, 2023, the remaining amount authorized to be repurchased under board-approved share repurchase authorizations was approximately $110.0 million, which has no expiration date. In addition, on April 27, 2023, our Board of Directors approved an increase to our quarterly dividend commencing in the second quarter of 2023 by 21% to $0.29 per common share and declared a special variable dividend of $5.00 per common share that will be paid during the second quarter of 2023.
COMMITMENTS, OFF-BALANCE SHEET ARRANGEMENTS AND CONTINGENCIES
We are party to a number of commitments and other financial arrangements, which may include off-balance sheet arrangements. At March 31, 2023, we guaranteed indebtedness owed to third parties of approximately $30.3 million, primarily related to dealer and end-user financing of equipment. In addition, we had accrued approximately $16.7 million of outstanding guarantees of residual values that may be owed to our finance joint ventures in the United States and Canada due upon expiration of certain eligible operating leases between the finance joint ventures and end users. The maximum potential amount of future payments under the guarantee is approximately $190.4 million. We also sell a majority of our wholesale receivables in North America, Europe and Brazil to our U.S., Canadian, European and Brazilian finance joint ventures. At March 31, 2023, we had outstanding designated and non-designated foreign currency contracts with a gross notional amount of approximately $4.2 billion. Refer to “Liquidity and Capital Resources” and “Item 3. Quantitative and Qualitative Disclosures about Market Risk-Foreign Currency Risk Management,” as well as to Notes 13, 15 and 19 of our Condensed Consolidated Financial Statements, for further discussion of these matters.
Contingencies
As part of routine audits, the Brazilian taxing authorities disallowed deductions relating to the amortization of certain goodwill recognized in connection with a reorganization of our Brazilian operations and the related transfer of certain assets to our Brazilian subsidiaries. Refer to Notes 12 and 19 of our Condensed Consolidated Financial Statements for further discussion of this matter.
During 2017, we purchased Precision Planting, which provides precision agricultural technology solutions. In 2018, Deere & Company (“Deere”) filed separate complaints in the U.S. District Court of Delaware against us and Precision Planting alleging that certain products of those entities infringed certain patents of Deere. The two complaints subsequently were consolidated into a single case. In July 2022, the case was tried before a jury, which determined that we and Precision Planting had not infringed the Deere patents. Following customary post-trial procedures, the Court entered a judgement in our favor, and in April 2023 Deere filed a Notice of Appeal. We have an indemnity right under the purchase agreement related to the acquisition of Precision Planting from its previous owner. Pursuant to that right, the previous owner of Precision Planting currently is responsible for the litigation costs associated with the complaint and is obligated to reimburse us for some or all of the damages in the event of an adverse outcome in the litigation. Refer to Note 19 of our Condensed Consolidated Financial Statements for further discussion of this matter.
OUTLOOK
Global industry demand for farm equipment, driven by continued strong commodity prices and healthy farm economics, is expected to be flat to moderately higher during 2023 in most major markets. Our net sales are expected to increase in 2023 compared to 2022, resulting from improved net sales volumes and pricing. Gross and operating margins are expected to improve from 2022 levels, reflecting the impact of higher net sales and production volumes, expected improvements in factory productivity, as well as pricing initiatives to offset material cost inflation. Engineering expenses and other technology investments are expected to increase during 2023 compared to 2022 to support our product development plans as well as our precision agriculture and digital initiatives.
37

Table of Contents
Our outlook is also based on current estimates of supplier component deliveries. If supply chain performance worsens, our results of operations will be adversely impacted. Refer to “Risk Factors” in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2022 for further discussion of the COVID-19 pandemic.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The discussion and analysis of our financial condition and results of operations are based upon our Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates estimates, including those related to discount and sales incentive allowances, deferred income taxes and uncertain income tax positions, pensions, goodwill, other intangible and long-lived assets, and recoverable indirect taxes. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. A description of critical accounting policies and related judgments and estimates that affect the preparation of our Condensed Consolidated Financial Statements is set forth in our Annual Report on Form 10-K for the year ended December 31, 2022.
FORWARD-LOOKING STATEMENTS
Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q are forward-looking, including certain statements set forth under the headings “Liquidity and Capital Resources” and “Outlook.” Forward-looking statements reflect assumptions, expectations, projections, intentions or beliefs about future events. These statements, which may relate to such matters as earnings, net sales, margins, industry demand, market conditions, commodity prices, farm incomes, foreign currency translation, general economic outlook, dividends, share repurchases, availability of financing, product development and enhancement, factory productivity, production and sales volumes, benefits from cost reduction initiatives, material costs, pricing impacts, tax rates, compliance with loan covenants, capital expenditures, working capital and debt service requirements and the impacts of the COVID-19 pandemic are “forward-looking statements” within the meaning of the federal securities laws. These statements do not relate strictly to historical or current facts, and you can identify certain of these statements, but not necessarily all, by the use of the words “anticipate,” “assumed,” “indicate,” “estimate,” “believe,” “predict,” “forecast,” “rely,” “expect,” “continue,” “grow” and other words of similar meaning. Although we believe that the expectations and assumptions reflected in these statements are reasonable in view of the information currently available to us, there can be no assurance that these expectations will prove to be correct.
These forward-looking statements involve a number of risks and uncertainties, and actual results may differ materially from the results discussed in or implied by the forward-looking statements. Adverse changes in any of the following factors could cause actual results to differ materially from the forward-looking statements:
• general economic and capital market conditions;
• availability of credit to our retail customers;
• the worldwide demand for agricultural products;
• grain stock levels and the levels of new and used field inventories;
• cost of steel and other raw materials;
• energy costs;
• performance and collectability of the accounts receivable originated or owned by AGCO or our finance joint ventures;
• government policies and subsidies;
• uncertainty regarding changes in the international tariff regimes and product embargoes and their impact on the cost of the products that we sell;
• weather conditions;
• interest and foreign currency exchange rates;
• pricing and product actions taken by competitors;
• commodity prices, acreage planted and crop yields;
• farm income, land values, debt levels and access to credit;
38

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
• pervasive livestock diseases;
• production disruptions, including due to component and raw material availability;
• production levels and capacity constraints at our facilities, including those resulting from plant expansions and systems upgrades;
• integration of recent and future acquisitions;
• our expansion plans in emerging markets;
• supply constraints, including energy shortages;
• our cost reduction and control initiatives;
• our research and development efforts;
• dealer and distributor actions;
• regulations affecting privacy and data protection;
• technological difficulties;
• the impact of the COVID-19 pandemic on product demand and production;
• the occurrence of future cyberattacks, including ransomware attacks; and
• the conflict in Ukraine.
We depend on suppliers for components, parts and raw materials for our products, and any failure by our suppliers to provide products as needed, or by us to promptly address supplier issues, will adversely impact our ability to timely and efficiently manufacture and sell products. Recently suppliers of several key parts and components have not been able to meet our demand and we have had to decrease our production levels. In addition, the potential of natural gas shortages in Europe, as well as predicted overall shortages in other energy sources, could also negatively impact our production and that of our supply chain in the future. It is unclear when these supply chain disruptions will be restored or what the ultimate impact on production, and consequently sales, will be.
International relations in the Pacific Rim remain in a state of flux, with, for instance, changes over the last few years in the international tariff regimes between the United States and China in response to various political issues and heightened uncertainty regarding China-Taiwan relations. This region is an important producer of parts and components that are critical to our products, particularly semiconductor chips. Should events in that region or between governments in that region and the countries in which we manufacture products deteriorate, it could significantly adversely impact the availability of parts and components to us, and, correspondingly, our ability to produce products at targeted levels.
We are subject to the risk of the imposition of limitations by governments on international transfers of funds.
For example, in recent years, the Argentine government has substantially limited the ability of companies to transfer funds out
of Argentina. As a consequence of these limitations, the spread between the official government exchange rate and the exchange rates resulting implicitly from certain capital market operations, usually effected to obtain U.S. dollars, has broadened
significantly. We have a wholly-owned subsidiary in Argentina that assembles and distributes agricultural equipment and replacement parts within Argentina. The net monetary assets of our operations in Argentina denominated in pesos at the official government rate were approximately 3.9 billion pesos (or approximately $18.5 million) as of March 31, 2023, inclusive of approximately 6.7 billion pesos (or approximately $32.0 million) in cash and cash equivalents. In addition, we have an obligation to reimburse AGCO Capital Argentina S.A., one of our finance joint ventures with Rabobank, up to $10 million under a guarantee related to the ability of AGCO Capital Argentina S.A. to transfer funds out of Argentina. The finance joint venture in Argentina has net monetary assets denominated in pesos at the official government rate of approximately 5.2 billion (or approximately $24.8 million) as of March 31, 2023, of which a majority is cash and cash equivalents. Future impairments and charges are possible in connection with these exposures.
In May 2022, we discovered that we had been subject to a sophisticated cyberattack. The attack resulted in the
temporary closure of most of our production sites and parts operations. A majority of the affected locations resumed operations
within approximately two weeks after the attack was discovered.
There was some data exfiltration as a result of the attack, and a portion of the exfiltrated data subsequently was released publicly. We do not have significant retail operations, and we do not believe that the exfiltrated data included privacy protected consumer data or that the exfiltration was consequential. We have invested heavily in maturing our information technology and cybersecurity operations and continue to review and improve our safeguards to minimize our exposure to future
39

Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(continued)
attacks. We do not believe the cost of remediation to the impacted systems will be material. To date, the cost of those efforts has not been consequential. We have cyber insurance coverage, and we filed a claim associated with the attack.
Any forward-looking statement should be considered in light of such important factors. For additional factors and additional information regarding these factors, see “Risk Factors” in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2022.
New factors that could cause actual results to differ materially from those described above emerge from time to time, and it is not possible for us to predict all of such factors or the extent to which any such factor or combination of factors may cause actual results to differ from those contained in any forward-looking statement. Any forward-looking statement speaks only as of the date on which such statement is made, and we disclaim any obligation to update the information contained in such statement to reflect subsequent developments or information except as required by law.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Foreign Currency Risk Management
For quantitative and qualitative disclosures about market risks, see “Quantitative and Qualitative Disclosures About Market Risks” in Item 7A of Part II of our Annual Report on Form 10-K for the year ended December 31, 2022. As of the first quarter of 2023, there has been no material change in our exposure to market risks.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of March 31, 2023, have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
The Company’s management, including the Chief Executive Officer and the Chief Financial Officer, does not expect that the Company’s disclosure controls or the Company’s internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and not be detected. We will conduct periodic evaluations of our internal controls to enhance, where necessary, our procedures and controls.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation described above that occurred during the three months ended March 31, 2023 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
40

Table of Contents
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are a party to various other legal claims and actions incidental to our business. These items are more fully discussed in Note 19 to our Condensed Consolidated Financial Statements.
ITEM 1A. RISK FACTORS
There have been no material changes to our risks and uncertainties disclosed under “Risk Factors” in Item 1A of Part 1 of our Annual Report on Form 10-K for the year ended December 31, 2022.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
There were no purchases of our common stock made by or on behalf of us during the three months ended March 31, 2023.
41

Table of Contents
ITEM 6. EXHIBITS
(The Company is not filing, under Item 4, instruments defining the rights of holders of long-term debt where the debt does not exceed 10% of the Company’s total assets. The Company agrees to furnish copies of those instruments to the Commission upon request.)

Exhibit Number |  | Description of Exhibit |  | The filings referenced for incorporation by reference are AGCO Corporation
31.1 |  | Certification of Eric P. Hansotia |  | Filed herewith
31.2 |  | Certification of Damon Audia |  | Filed herewith
32.1 |  | Certification of Eric P. Hansotia and Damon Audia |  | Furnished herewith
101 |  | The following unaudited financial information from this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, are formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Comprehensive Income; (iv) Condensed Consolidated Statements of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements |  | Filed herewith
104 |  | Cover Page Interactive Data File - the cover page from this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 is formatted in Inline XBRL |  | Filed herewith

42

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: | May 9, 2023 |  | /s/ Damon Audia
|  |  | Damon Audia Senior Vice President and Chief Financial Officer (Principal Financial Officer)
|  |  | /s/ Lara T. Long
|  |  | Lara T. Long Vice President, Chief Accounting Officer (Principal Accounting Officer)

43